+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46252

Chapter 46252 provides scholary research titles of which PDF Full Texts are available through EurekaMag.

Ideo, H.; Seko, A.; Ohkura, T.; Matta, K.L.; Yamashita, K., 2002:
High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside

Trust, T.J.; Kostrzynska, M.; Emödy, L.; Wadström, T., 1993:
High-affinity binding of the basement membrane protein collagen type IV to the crystalline virulence surface protein array of Aeromonas salmonicida

Johnson, D.G.; Coleman, A.; Powell, K.L.; MacLeod, M.C., 1997:
High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts

Shi, Y.; Zou, M.; Parhar, R.S.; Farid, N.R., 1993:
High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells

Inoue, K.; Shimada, H.; Ueba, J.; Enomoto, S.; Tanaka-Saisaka, Y.; Kubota, T.; Koyama, M.; Morita, T., 1996:
High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII

Happe, H.K.; Murrin, L.C., 1993:
High-affinity choline transport sites: use of [3H]hemicholinium-3 as a quantitative marker

van Twuyver, E.; Mooijaart, R.J.; ten Berge, I.J.; van der Horst, A.R.; Wilmink, J.M.; Claas, F.H.; de Waal, L.P., 1994:
High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion--the other side of the coin

Homma, M.; Suzuki, H.; Kusuhara, H.; Naito, M.; Tsuruo, T.; Sugiyama, Y., 1998 :
High-affinity efflux transport system for glutathione conjugates on the luminal membrane of a mouse brain capillary endothelial cell line (MBEC4)

Yang, R.; Yang, X.L., 2001:
High-affinity glutamate transporters

Kuyper, L.F.; Baccanari, D.P.; Jones, M.L.; Hunter, R.N.; Tansik, R.L.; Joyner, S.S.; Boytos, C.M.; Rudolph, S.K.; Knick, V.; Wilson, H.R.; Caddell, J.M.; Friedman, H.S.; Comley, J.C.; Stables, J.N., 1996:
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size

Wilcox, R.E.; Ragan, J.E.; Pearlman, R.S.; Brusniak, M.Y.; Eglen, R.M.; Bonhaus, D.W.; Tenner, T.E.; Miller, J.D., 2002:
High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors

Kilpatrick, K.E.; Danger, D.P.; Hull-Ryde, E.A.; Dallas, W., 2000:
High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 microg of DNA

Bogdanffy, M.S.; Manning, L.A.; Sarangapani, R., 1999:
High-affinity nasal extraction of vinyl acetate vapor is carboxylesterase dependent

Koenderink, J.B.; Hermsen, H.P.; Swarts, H.G.; Willems, P.H.; D.P.nt, J.J., 2000:
High-affinity ouabain binding by a chimeric gastric H+,K+-ATPase containing transmembrane hairpins M3-M4 and M5-M6 of the alpha 1-subunit of rat Na+,K+-ATPase

Jacobsen, E.J.; TenBrink, R.E.; Stelzer, L.S.; Belonga, K.L.; Carter, D.B.; Im, H.K.; Im, W.B.; Sethy, V.H.; Tang, A.H.; VonVoigtlander, P.F.; Petke, J.D., 1996:
High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex

Wong, D.W.; Robertson, G.H., 1999:
High-affinity peptide ligands for pancreatic alpha-amylase by phage display

Rajeev, K.G.; Maier, M.A.; Lesnik, E.A.; Manoharan, M., 2002:
High-affinity peptide nucleic acid oligomers containing tricyclic cytosine analogues

Breyer-Pfaff, U.; Nill, K., 1999:
High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver

Nakamura, H.; Huang, S.H.; Takakura, K., 1996:
High-affinity taurine uptake and its regulation by protein kinase C in human glioma cells

Röver, S.; Adam, G.; Cesura, A.M.; Galley, G.; Jenck, F.; Monsma, F.J.; Wichmann, J.; Dautzenberg, F.M., 2001:
High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor

Anonymous, 2002:
High-alert medications and patient safety

Basnyat, B., 1999:
High-altitude cerebral edema

Greene, H.M.; Wickler, S.J.; Anderson, T.P.; Cogger, E.A.; Lewis, C.C.; Wyle, A., 2000:
High-altitude effects on respiratory gases, acid-base balance and pulmonary artery pressures in equids

Basnyat, B., 2001:
High-altitude emergency medicine

Ogilvie, R.I., 2001:
High-altitude illness

Finsterer, J., 2000:
High-altitude illness induced by tooth root infection

McMahon, C.J.; Hicks, J.M.; Dreyer, W.J., 2001:
High-altitude precipitation and exacerbation of protein-losing enteropathy after a Fontan operation

Goetz, A.E.; Kuebler, W.M.; Peter, K., 1996:
High-altitude pulmonary edema

de Clari, F.; von Albertini, M., 1996:
High-altitude pulmonary edema

Voelkel, N.F., 2002:
High-altitude pulmonary edema

Hultgren, H.N.; Honigman, B.; Theis, K.; Nicholas, D., 1996:
High-altitude pulmonary edema at a ski resort

Gabry, Aé.Louis.; Ledoux, X.; Mozziconacci, M.; Martin, C., 2003:
High-altitude pulmonary edema at moderate altitude (< 2,400 m; 7,870 feet): a series of 52 patients

Kobayashi, T., 1995:
High-altitude pulmonary edema in Japan

Sartori, C.; Trueb, L.; Scherrer, U., 1997:
High-altitude pulmonary edema. Mechanisms and management

Angerio, A.D.; Kot, P.A., 1996:
High-altitude pulmonary edema: a clinical crisis

Arnett, F.C., 1998:
High-altitude pulmonary edema: an immunogenetically mediated disease?

Scherrer, U.; Sartori, C.; Lepori, M.; Allemann, Y.; Duplain, H.; Trueb, L.; Nicod, P., 2000:
High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport

Schoene, R.B., 2002:
High-altitude pulmonary edema: more lessons from the master

Niazova, Z.A.; Batyraliev, T.A.; Aikimbaev, K.S.; Kudaiberdieva, G.Z.; Akgul, F.; Soodanbekova, Y.K.; Birand, A., 1996:
High-altitude pulmonary hypertension: effects of captopril on pulmonary and systemic arterial pressures

Petculescu, G.; Wilen, L.A., 2001:
High-amplitude thermoacoustic effects in a single pore

Mitsuishi, K.; Kawasaki, M.; Takeguchi, M.; Yasuda, H.; Furuya, K., 2001:
High-angle annular dark-field STEM observation of Xe nanocrystals embedded in Al

Liu, C.P.; Twesten, R.D.; Gibson, J.M., 2001:
High-angle annular dark-field imaging of self-assembled Ge islands on Si(0 0 1)

Liu; Nowak; Jaeger; Vuchic; Merkle; Buchholz; Chang, 1995:
High-angle grain-boundary junctions in YBa2Cu3O7: Normal-state resistance and 1/f noise

Via; Bauer; Potemski; Maan; Mendez; Wang, 1988:
High-angular-momentum excitons in GaAs/Ga1-xAlxAs quantum wells

de Boer MP.N.ordam; Muller, 1993:
High-angular-momentum states as population traps in multiphoton ionization

Dutta, S.K.; Feldbaum, D.; Walz-Flannigan, A.; Guest, J.R.; Raithel, G., 2001:
High-angular-momentum states in cold Rydberg gases

Xu; Cooke, 1993:
High-angular-momentum transfer during the autoionization of the 6p1/2nd J=3 states of barium

Sheppard, C.J., 2001:
High-aperture beams

Cronin; Torok; Varga; Cogswell, 2000:
High-aperture diffraction of a scalar, off-axis Gaussian beam

Richardson; McKenty; Keck; Marshall; Roback; Verdon; McCrory; Soures; Lane, 1986:
High-aspect-ratio laser-fusion targets driven by 24-beam uv laser radiation

Matsuki, Y.; Suzuki, K.; Kawakami, M.; Ishizuka, T.; Kawaguchi, Y.; Hidaka, T.; Nakamura, H., 1996:
High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns

Alessi, N., 2002:
High-bandwidth interactive telepsychiatry

Canada, T.Andrew.; Xue, Z., 2002:
High-basicity determination in mixed water-alcohol solutions by a dual optical sensor approach

Ware, A.S.; Hirshman, S.P.; Spong, D.A.; Berry, L.A.; Deisher, A.J.; Fu, G.Y.; Lyon, J.F.; Sanchez, R., 2002:
High-beta equilibria of drift-optimized compact stellarators

Chan, B.; Anderson, G.M.; Thériault, M.E., 1998:
High-billing general practitioners and family physicians in Ontario: how do they do it? An analysis of practice patterns of GP/FPs with annual billings over $400,000

Cheng, T-Chi.; Victoria-Feser, M-Pia., 2002:
High-breakdown estimation of multivariate mean and covariance with missing observations

Nisoli, M.; Priori, E.; Sansone, G.; Stagira, S.; Cerullo, G.; D.S.lvestri, S.; Altucci, C.; Bruzzese, R.; de Lisio, C.; Villoresi, P.; Poletto, L.; Pascolini, M.; Tondello, G., 2002:
High-brightness high-order harmonic generation by truncated bessel beams in the sub-10-fs regime

Masterson; Tanner; Patrick; Wieman, 1993:
High-brightness, high-purity spin-polarized cesium beam

Kennedy, J.S.; Stranahan, P.L.; Taylor, K.D.; Chandler, J.G., 1998:
High-burst-strength, feedback-controlled bipolar vessel sealing

Ganzoni, A.; Heilig, P.; Schönenberger, K.; Hügli, O.; Fitting, J.W.; Brändli, O., 1994:
High-caloric nutrition in chronic obstructive lung disease

Kochanek, S.; Schiedner, G.; Volpers, C., 2001:
High-capacity 'gutless' adenoviral vectors

Rey, M.A., 2001:
High-capacity cation-exchange column for enhanced resolution of adjacent peaks of cations in ion chromatography

Berridge, M.V.; Tan, A.S., 2001:
High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases

Lowenstein, P.R.; Thomas, C.E.; Umana, P.; Gerdes, C.A.; Verakis, T.; Boyer, O.; Tondeur, S.; Klatzmann, D.; Castro, M.G., 2002:
High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain

Poumay, Y.; Herphelin, F.; Smits, P.; D.P.tter, I.Y.; Pittelkow, M.R., 1999:
High-cell-density phorbol ester and retinoic acid upregulate involucrin and downregulate suprabasal keratin 10 in autocrine cultures of human epidermal keratinocytes

Keyes, 1990:
High-chirality blue-phase lattices are unstable: A theory for the formation of blue phase III

Tanosaki, R.; Okamoto, S., 1996:
High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy

Langmann, G.; Pendl, G.; Müllner, K.; Feichtinger, K.H.; Papaefthymiouaf, G., 2003:
High-compared with low-dose radiosurgery for uveal melanomas

Jenkins, D.J.A.; Kendall, C.W.C.; Augustin, L.S.A.; Vuksan, V., 2003:
High-complex carbohydrate or lente carbohydrate foods?

Thomas, S., 1996:
High-compression bandages

Katayama, I.; Ohkawara, A.; Ohkido, M.; Harada, S.; Tamaki, K.; Nakagawa, H.; Hori, Y.; Nishiyama, S., 2002:
High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids

Quinones; Ford; Guiochon, 2000:
High-concentration band profiles and system peaks for a ternary solute system

Nishio, M.; Choi, C.S.; Gevirtz, C.M., 1998:
High-concentration cisatracurium in intensive care unit solution

Chi, Z.; Liu, J.; Xu, P., 1995:
High-concentration ethanol production from cooked corn starch by using medium-temperature cooking process

Ling, 1994 :
High-concentration point-defect chemistry: Statistical-thermodynamic approach applied to nonstoichiometric cerium dioxides

Radwan, I.A.; Saito, S.; Goto, F., 2002:
High-concentration tetracaine for the management of trigeminal neuralgia: quantitative assessment of sensory function after peripheral nerve block

Günter, S.; Gude, A.; Maraschek, M.; Sesnic, S.; Zohm, H.; Howell, D.F., 2002:
High-confinement regime at high beta(N) values due to a changed behavior of the neoclassical tearing modes

Johnston, J.R., 1994:
High-conflict divorce

Daria, V.R.; Miranda, J.J.; Saloma, C., 2002:
High-contrast images of semiconductor sites via one-photon optical beam-induced current imaging and confocal reflectance microscopy

Natarajan; Behringer; Timp, 1996:
High-contrast, high-resolution focusing of neutral atoms using light forces

McManus, M.; Newacheck, P.; Kelly, R.; Macklin, M., 1992:
High-cost children: the unknown liability

Mattera, M.D., 1996:
High-cost health care?

Thompson, C.A., 2002:
High-cost sepsis drug forces pharmacists to weigh patients' future

Garfinkel, S.A.; Riley, G.F.; Iannacchione, V.G., 1989:
High-cost users of medical care

Tuman, K.J.; Ivankovich, A.D., 1993 :
High-cost, high-tech medicine: are we getting our money's worth?

Hornsey; Marsh; Cleaver; Ahmed, 1995:
High-current ballistic transport through variable-width constrictions in a high-mobility two-dimensional electron gas

Mensz; Tsui, 1989:
High-current effects in magnetotransport of two-dimensional electrons in GaAs/AlxGa1-xAs heterostructures

Sudan, 1993:
High-current ion-ring accelerator

SoRelle, R., 1998:
High-definition television and telemetry

von Orelli, A.; Lehareinger, Y.; Rol, P.; Niederer, P.; Doswald, D.; Felber, N., 1999:
High-definition true-colour television for use in minimally invasive medical procedures

Ferrari, E.; Dupré-Minet, M.; Laffond, C.; Amselem, J.; Baudouy, M.; Morand, P., 1993:
High-degree atrioventricular block revealing the first case of Lyme's disease in the Alpes-Maritimes department

Fraunhofer, S.; Kiossis, D.; Helmberger, H.; von Sommoggy, S.; Maurer, P.C., 1994:
High-degree bilateral carotid stenoses

Rösby, O.; Aleström, P.; Berg, K., 1998:
High-degree sequence conservation in LPA kringle IV-type 2 exons and introns

van Belkum, A.; Troesch, A., 2003:
High-density DNA arrays for comparative genomics and epidemiological studies in clinical microbiology

Krauser, J.T., 1996 :
High-density PTFE membranes: uses with root-form implants

Steinmetz, L.M.; Davis, R.W., 2001:
High-density arrays and insights into genome function

Roy, 1985:
High-density behavior in supersymmetry

Le; Lax; Vojak; Calawa, 1985:
High-density excitonic state in two-dimensional multiple quantum wells

Leung; Pei, 1989:
High-density expansions of the relativistic Thomas-Fermi equation

Ferguson, J.A.; Steemers, F.J.; Walt, D.R., 2000:
High-density fiber-optic DNA random microsphere array

Epstein, J.R.; Lee, M.; Walt, D.R., 2002:
High-density fiber-optic genosensor microsphere array capable of zeptomole detection limits

Banik, G.G.; Heath, C.A., 1996:
High-density hybridoma perfusion culture. Limitation vs inhibition

Alvarez; Barbón; Nieto, 1990:
High-density limit of hot chiral matter

Kivatinitz, S.C.; Pelsman, M.A.; Alonso, A.C.; Bagatolli, L.; Quiroga, S., 1998:
High-density lipoprotein aggregated by oxidation induces degeneration of neuronal cells

Bloomfield Rubins, H., 2002:
High-density lipoprotein and coronary heart disease: lessons from recent intervention trials

Dansky, H.M.; Fisher, E.A., 1999:
High-density lipoprotein and plaque regression: the good cholesterol gets even better

Sheikh, K., 2001:
High-density lipoprotein cholesterol and risk of stroke

Tonkin, A., 2002:
High-density lipoprotein cholesterol and treatment guidelines

Boden, W.E., 2001:
High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial

Mänttäri, M.; Tenkanen, L.; Mäenpää, H.; Manninen, V.; Huttunen, J.K., 1993:
High-density lipoprotein cholesterol elevation with gemfibrozil: effects of baseline level and modifying factors

Medina; Nunes; Carrilho; Shimabukuru; Lottenberg; Lottenberg; McPherson; Krauss; Quintão, 2000:
High-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus

Zuliani, G.; Palmieri, E.; Volpato, S.; Bader, G.; Mezzetti, A.; Costantini, F.; Sforza, G.R.; Imbastaro, T.; Romagnoni, F.; Fellin, R., 1998:
High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: a cross sectional study. Associazione Medica Sabin

Watts, G.F.; Barrett, P.H., 2002:
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy

Ko, Y.; Häring, R.; Stiebler, H.; Wieczorek, A.J.; Vetter, H.; Sachinidis, A., 1993:
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells

Silverman, D.I.; Ginsburg, G.S.; Pasternak, R.C., 1993:
High-density lipoprotein subfractions

Benvenga, S.; Alesci, S.; Trimarchi, F., 2002:
High-density lipoprotein-facilitated entry of thyroid hormones into cells: a mechanism different from the low-density lipoprotein-facilitated entry

Toth, P.P., 2001:
High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects

Rong, J.X.; Fisher, E.A., 2001:
High-density lipoprotein: gene-based approaches to the prevention of atherosclerosis

Ivanchenkova, R.A.; Sviridov, A.V.; Ozerova, I.N.; Perova, N.V.; Grachev, S.V., 2000:
High-density lipoproteins in cholesterosis of the gall bladder

Matzilevich, D.A.; Rall, J.M.; Moore, A.N.; Grill, R.J.; Dash, P.K., 2002:
High-density microarray analysis of hippocampal gene expression following experimental brain injury

Pantoliano, M.W.; Petrella, E.C.; Kwasnoski, J.D.; Lobanov, V.S.; Myslik, J.; Graf, E.; Carver, T.; Asel, E.; Springer, B.A.; Lane, P.; Salemme, F.R., 2002:
High-density miniaturized thermal shift assays as a general strategy for drug discovery

Peng, J.H.; Fahima, T.; Röder; Huang, Q.Y.; Dahan, A.; Li, Y.C.; Grama, A.; Nevo, E., 2001:
High-density molecular map of chromosome region harboring stripe-rust resistance genes YrH52 and Yr15 derived from wild emmer wheat, Triticum dicoccoides

Burton, S.S.; Liebig, T.; Frazier, S.D.; Ros, P.R., 1997:
High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting

Segerson, E.C.; Beetham, P.K., 2001:
High-density ovine endometrial cells exhibit natural killer activity during early pregnancy

Zhang, J.; Collins, A.; Chen, M.; Knyazev, I.; Gentz, R., 1999:
High-density perfusion culture of insect cells with a biosep ultrasonic filter

Odum, B.C.; Bussard, G.M.; Lewis, R.P.; Lara, W.C.; Edlich, R.F.; Gampper, T.J., 1997:
High-density porous polyethylene for facial bone augmentation

Poelker; Coulter; Holt; Jones; Kowalczyk; Young; Zeidman; Toporkov, 1994:
High-density production of spin-polarized atomic hydrogen and deuterium

Rosenfeld, 1986:
High-density properties of integral-equation theories of fluids: Universal analytic structure and details for the one-component plasma

Rosenfeld, 1985:
High-density properties of liquid-state theories: Physically intuitive meaning for the direct correlation functions

Demontis; Klein; LeSar, 1989:
High-density structures and phase transition in an ionic model of H2O ice

Fruchtman, 1988:
High-density thick-beam free-electron laser

Townsend; Edwards; Zetie; Cooper; Rink; Foot, 1996:
High-density trapping of cesium atoms in a dark magneto-optical trap

Takasu, Y.; Honda, K.; Komori, K.; Kuwamoto, T.; Kumakura, M.; Takahashi, Y.; Yabuzaki, T., 2003:
High-density trapping of cold ytterbium atoms by an optical dipole force

Abele-Horn, M.; Scholz, M.; Wolff, C.; Kolben, M., 2000:
High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery

Wu, S-Ya.; Ho, J-Der.; Ho, C-Lien.; Chen, S-Ni.; Tsai, R.Jui-fang., 2002:
High-density vitreous substitute in the management of advanced Coats' disease

Nion, S.; Briand, O.; Lestavel, S.; Torpier, G.; Nazih, F.; Delbart, C.; Fruchart, J.C.; Clavey, V., 1998:
High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins

Richardson, L.Y., 2002:
High-dependency care: developing a joint surgical recovery unit

Elliott, M., 1997:
High-dependency nursing

Prien, T., 1999:
High-dependency units: reducing the cost of intensive care without loss of quality

Orsholm; Csillag; Borglund, 2000:
High-detective-quantum-efficiency fast-electron detector for electron energy loss spectroscopy

Yang, Y.; Stark, H.; Gurkan, D.; Lawson, C.L.; Cohn, R.W., 2000:
High-diffraction-efficiency pseudorandom encoding

L.B.rre M.R.ssayre; Tallet; Gibbs, 1986:
High-dimension chaotic attractors of a nonlinear ring cavity

Fischer; Hess; Elsa; Göbel, 1994:
High-dimensional chaotic dynamics of an external cavity semiconductor laser

Ashburner, J.; Andersson, J.L.; Friston, K.J., 1999:
High-dimensional image registration using symmetric priors

Chian, A.C-L.; Rempel, E.L.; Macau, E.E.; Rosa, R.R.; Christiansen, F., 2002:
High-dimensional interior crisis in the Kuramoto-Sivashinsky equation

Posener, J.A.; Wang, L.; Price, J.L.; Gado, M.H.; Province, M.A.; Miller, M.I.; Babb, C.M.; Csernansky, J.G., 2002:
High-dimensional mapping of the hippocampus in depression

Kieser, J.A.; Groeneveld, H.T., 1992:
High-dimensional plots in the evaluation of interpopulation differences in human tooth size

Gross; Hammer; Scheffler; Brenig, 1994:
High-dimensional quantum dynamics of adsorption and desorption of H2 at Cu(111)

Solano, C.; Sola, C.; Lluch, A.; Hornedo, J.; López, J.; Cortés-Funes, H.; García-Conde, J., 1997:
High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative study

Sola, C.; Ojeda, B.; Brunet, J.; López López, J.J., 1997:
High-dosage chemotherapy in breast cancer

van der Hoeven, J.G.; Compier, E.A.; Meinders, A.E., 1993:
High-dosage epinephrine in patients with cardiopulmonary arrest outside of the hospital?

Müller, C.; Axthelm, E.H., 1995:
High-dosage systemic lysis of a fulminant pulmonary embolism in an echocardiographically recognized mobile thrombus of the right heart

Trehan, M.; Taylor, C.R., 2002:
High-dose 308-nm excimer laser for the treatment of psoriasis

Hofheinz, R-D.; Hartung, G.; Samel, S.; Hochhaus, A.; Pichlmeier, U.; Post, S.; Hehlmann, R.; Queisser, W., 2002:
High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study

Yeh, K.H.; Cheng, A.L., 1997:
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy

Navis, G.; Kramer, A.B.; de Jong, P.E., 2002:
High-dose ACE inhibition: can it improve renoprotection?

Argiris, A.; Seropian, S.; Cooper, D.L., 2000:
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease

Fields; Agaliotis; Janssen; Perkins; Ballester; Hiemenz; Zorsky; Elfenbein, 1994:
High-dose Chemotherapy and the Treatment of Metastatic Breast Cancer: Selecting the Regimen and the Source of Stem Cells

Tauchert, M.; Gildor, A.; Lipinski, J., 1999:
High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure

Leissinger, C.; Becton, D.; Cornell, C.; Cox Gill, J., 2001:
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

Anonymous, 2001:
High-dose IL-2 without HAART

Black, W.C., 1994:
High-dose MR in the evaluation of brain metastases: will increased detection decrease costs?

Tepe; Dinkelborg; Muschik; Dietrich; Claussen; Noll; Wiskirchen; Duda, 2000:
High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty

Reeker, W.; Werner, C.; Möllenberg, O.; Mielke, L.; Kochs, E., 2000:
High-dose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia in rats

Weeston, T.F.; Constantino, J., 1996:
High-dose T4 for rapid-cycling bipolar disorder

Stege, H.; Schöpf, E.; Ruzicka, T.; Krutmann, J., 1996:
High-dose UVA1 for urticaria pigmentosa

Barkholt, L.; Lewensohn-Fuchs, I.; Ericzon, B.G.; Tydén, G.; Andersson, J., 2001:
High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients

Abeloff, M.D., 1993:
High-dose adjuvant chemotherapy for high-risk breast cancer

Anonymous, 2002:
High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question

Licata, A.G., 1999:
High-dose adjuvant interferon therapy for melanoma

Lipman, J.; Wilson, W.; Kobilski, S.; Scribante, J.; Lee, C.; Kraus, P.; Cooper, J.; Barr, J.; Moyes, D., 1993:
High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation: a double-blind randomised trial

Joynt, G.; Doedens, L.; Lipman, J.; Bothma, P., 1996:
High-dose adrenaline with low systemic vascular resistance and symmetrical peripheral gangrene

Fisher, R.I.; Rosenberg, S.A.; Sznol, M.; Parkinson, D.R.; Fyfe, G., 1998:
High-dose aldesleukin in renal cell carcinoma: long-term survival update

Argilés, A.; Lorho, R.; Mourad, G.; Mion, C.M., 1993:
High-dose alfacalcidol for anaemia in dialysis

Reed, M.D., 1999:
High-dose amoxicillin in new guidelines for treatment of otitis media in children

Herranz, M.T.; Molina, M.A.; Corrales, A.; Almagro, M., 1998:
High-dose amphotericin B in the treatment of rhino-cerebral mucormycosis: a case with an unusual evolution

Radosavljević, D.; Jelić, S.; Tomasević, Z.; Matković, S.; Stamatović, L.; Nikolić-Tomasević, Z.; Popov, I., 2001:
High-dose anthracyclines in the treatment of advanced primitive neuroectodermal tumors in adults--a single institution experience

Iba, T.; Kidokoro, A., 2000:
High-dose antithrombin therapy for sepsis

Iba, T.; Kidokoro, A., 2002:
High-dose antithrombin therapy for sepsis: mechanisms of action

Tassani, P.; Augustin, N.; Barankay, A.; Braun, S.L.; Zaccaria, F.; Richter, J.A., 2001:
High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery

Shulman, S.T., 1999:
High-dose aspirin in Kawasaki disease

Kavløy, S.; Holte, H.; Kvalheim, G., 1994:
High-dose autologous stem cell support in malignant diseases--an established method, uncertain indication

Saito, N.; Takemori, N.; Hirai, K.; Onodera, R.; Watanabe, S.; Kohgo, Y., 1996:
High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura

Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M., 1998:
High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma

Marrouche, N.F.; Reddy, R.K.; Wittkowsky, A.K.; Bardy, G.H., 2000:
High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial

Schnider, P.; Moraru, E.; Kittler, H.; Voller, B.; Auff, E., 2000:
High-dose botulinum toxin type A for axillary hyperhidrosis

Wollina, U.; Karamfilov, T.; Konrad, H., 2002:
High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval

Corsa, P.; Parisi, S.S.; Raguso, A.; el Jaouni, M.; Fusco, V.; Maiorana, A.; Lauriola, P.; D.C.rcia, A.; D.C.smo, V.; Albano, A., 1997:
High-dose brachytherapy in endobronchial neoplastic stenoses

Micke, O.; Schäfer, U.; Prott, F.J.; Wassmann, H.; Willich, N., 1999:
High-dose brachytherapy in malignant brain tumors--history, procedure and personal experience

Ikuta, K.; Fujioka, K.; Sumita, H.; Takahashi, H.; Sekiguchi, H.; Kai, S.; Kajigaya, Y.; Funabiki, T.; Sakai, H.; Matsuyama, S., 1993:
High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia

Schiffman, K.; Buckner, C.D.; Maziarz, R.; Maloney, D.G.; Appelbaum, F.R.; Press, O.; Gooley, T.; Holmberg, L.; Lilleby, K.; Clift, R.; Zuckerman, N.; Klarnet, J.; Weaver, C.; Chauncey, T.; Bensinger, W.I., 1998:
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease

Kalous, O.; Mayer, J.; Malásková, L., 2002:
High-dose busulfan--monitoring plasma levels and dosage adjustments in adults

Benazzo, M.; Bernardo, G.; Corbella, F.; Danova, M.; Lanza, L.; Zappoli, F.; Uggetti, C.; Mira, E., 1996:
High-dose carboplatin superselective intraarterial chemotherapy in advanced head and neck cancer

Siegert, W., 1993:
High-dose carboplatin, etoposide and ifosfamide and autologous stem cell rescue in the treatment of non-Hodgkin lymphoma

Benedetti Panici, P.; Pierelli, L.; Scambia, G.; Foddai, M.L.; Salerno, M.G.; Menichella, G.; Vittori, M.; Maneschi, F.; Caracussi, U.; Serafini, R.; Leone, G.; Mancuso, S., 1997:
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration

Dunkel, I.J.; Boyett, J.M.; Yates, A.; Rosenblum, M.; Garvin, J.H.; Bostrom, B.C.; Goldman, S.; Sender, L.S.; Gardner, S.L.; Li, H.; Allen, J.C.; Finlay, J.L., 1998:
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

Arnold, K., 1999:
High-dose chemo and breast cancer: early results spark debate

Nademanee, A.; Molina, A.; Fung, H.; Stein, A.; Parker, P.; Planas, I.; O'Donnell, M.R.; Snyder, D.S.; Kashyap, A.; Spielberger, R.; Bhatia, R.; Krishnan, A.; Sniecinski, I.; Vora, N.; Slovak, M.; Dagis, A.; Niland, J.C.; Forman, S.J., 1999:
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission

Burdach, S.; Jürgens, H., 2002:
High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)

Freedman, A.S.; Neuberg, D.; Gribben, J.G.; Mauch, P.; Soiffer, R.J.; Fisher, D.C.; Anderson, K.C.; Andersen, N.; Schlossman, R.; Kroon, M.; Ritz, J.; Aster, J.; Nadler, L.M., 1998:
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

Tanosaki, R.; Okamoto, S.; Takahashi, S.; Inoue, T.; Kikuno, K.; Aoki, Y.; Takada, M.; Irie, S.; Shimane, M.; Tojo, A., 1993:
High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)

Douer, D.; Levine, A.; Anderson, W.F.; Gordon, M.; Groshen, S.; Khan, A.; Mohrbacher, A.; Muggia, F.; Shibata, D., 1996:
High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults

Handberg, J.; Hansen, S.W., 1996:
High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review

Decatris, M.P.; Wilkinson, P.M.; Welch, R.S.; Metzner, M.; Morgenstern, G.R.; Dougall, M., 2000:
High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity

de Castro, Cáudio.Galvão.; de Almeida, S.Geiger.; Gregianin, L.José.; Loss, J.Fagundes.; Rivero, Lís.Fernando.; Schwartsmann, G.; Brunetto, A.Lunardi., 2003:
High-dose chemotherapy and autologous peripheral blood stem cell rescue in a patient with pleuropulmonary blastoma

Tanaka, K.; Matsunobu, T.; Sakamoto, A.; Matsuda, S.; Iwamoto, Y., 2002:
High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors

Hwang, Y.K.; Goh, Y.T.; Linn, Y.C.; Tan, C.H.; Tan, H.C., 2000:
High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option

deMagalhaes-Silverman, M.; Bloom, E.; Lembersky, B.; Lister, J.; Pincus, S.; Rybka, W.; Voloshin, M.; Wilson, J.; Ball, E., 1997:
High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer

Avigdor, A.; Hardan, I.; Shpilberg, O.; Raanani, P.; Grotto, I.; Ben-Bassat, I., 2000:
High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer

Vose, J.M.; Armitage, J.O.; Kessinger, A., 1993:
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells

Gianni, A.M., 1997:
High-dose chemotherapy and autotransplants: a time for guidelines

Ravaud, P.; Fermand, J.P., 1993:
High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits

Gradishar, W.J., 1999:
High-dose chemotherapy and breast cancer

Damon, L.E.; Hu, W.W.; Stockerl-Goldstein, K.E.; Blume, K.G.; Wolf, J.L.; Gold, E.; Cecchi, G.R.; Irwin, D.; Glaspy, J.; Territo, I.; Miller, W.; Mason, J.R.; Linker, C.A., 2000:
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California

Mugishima, H., 1999:
High-dose chemotherapy and hematopoietic stem cell transplant in the treatment of advanced neuroblastoma

Vose, J.M., 1998:
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma

Stuart, M.J.; Peters, W.P.; Broadwater, G.; Hussein, A.; Ross, M.; Marks, L.B.; Folz, R.J.; Long, G.D.; Rizzieri, D.; Chao, N.J.; Vredenburgh, J.J., 2003:
High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes

Peters, W.P.; Dansey, R.D.; Klein, J.L.; Baynes, R.D., 2000:
High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer

Rosti, G.; Ferrante, P.; Tienghi, A.; Turci, D.; Dazzi, C.; Leoni, M.; Fiorentini, G.; Ferrari, E.; Zornetta, L.; Marangolo, M., 1996:
High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors

Pont, J.; Höltl, W.; Weissbach, L.; Beyer, J.; Siegert, W., 1998:
High-dose chemotherapy and reinfusion of hematopoietic stem cells in advanced germ cells tumors with poor prognosis--the position in 1996

Anonymous, 1996:
High-dose chemotherapy and stem cell transplantation in solid tumors. Proceedings of a meeting. Berlin, Germany, 27-28 April 1996

Pedrazzoli, P.; D.P.ada, G.A.; Robustelli della Cuna, G., 1998:
High-dose chemotherapy and stem-cell support in breast cancer

Stiff, P.J.; Bayer, R.; Tan, S.; Camarda, M.; Sosman, J.; Peace, D.; Kinch, L.; Rad, N.; Loutfi, S., 1995:
High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial

Bierman, P.J.; Anderson, J.R.; Freeman, M.B.; Vose, J.M.; Kessinger, A.; Bishop, M.R.; Armitage, J.O., 1996:
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy

van den Hoogen, F.H.; Schattenberg, A.V.; Breedveld, F.C.; Fibbe, W.E.; van de Putte, L.B., 1998:
High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases

Matsuura, H.; Sakurai, M.; Arima, K., 1999:
High-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced extragonadal germ cell tumor--a case report

Jillella, A.P.; Helman, S.W.; Larison, J.; Litaker, M.S.; Cook, L.O., 2001:
High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period

Chabannon, C.; Cornetta, K.; Lotz, J.P.; Rosenfeld, C.; Shlomchik, M.; Yanovitch, S.; Marolleau, J.P.; Sledge, G.; Novakovitch, G.; Srour, E.F.; Burtness, B.; Camerlo, J.; Gravis, G.; Lee-Fischer, J.; Faucher, C.; Chabbert, I.; Krause, D.; Maraninchi, D.; Mills, B.; Kunkel, L.; Oldham, F.; Blaise, D.; Viens, P., 1998:
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

Bearman, S.I., 2000:
High-dose chemotherapy for breast cancer

Durant, J.R., 1999:
High-dose chemotherapy for breast cancer in USA

Gianni, L., 2002:
High-dose chemotherapy for breast cancer: any use for it?

Lopez, M., 1999:
High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?

Martin, M., 1995:
High-dose chemotherapy for breast cancer: clinical advantages of autologous peripheral blood progenitor cells (PBPC) compared with autologous bone marrow transplantation (ABMT)

Antman, K.; Tiersten, A., 1999:
High-dose chemotherapy for breast cancer: evolving data

Bearman, S.I., 2000:
High-dose chemotherapy for breast cancer: we have not heard the final word

Norton, L., 2001:
High-dose chemotherapy for breast cancer: "how do you know?"

Byers, T.; Vance, R.; Bigelow, C., 2002:
High-dose chemotherapy for breast cancer?

Khouri, I.F.; Keating, M.J., 1998:
High-dose chemotherapy for chronic lymphocytic leukemia: eligibility, timing, and benefit?

Motzer, R.J., 1996:
High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center

Recht, A., 1996:
High-dose chemotherapy for metastatic breast cancer

Kleeberg, U.R., 2000:
High-dose chemotherapy for metastatic breast cancer without certain advantages so far

Aebi, S.; Castiglione-Gertsch, M., 2001:
High-dose chemotherapy for ovarian cancer: are we ready to go?

Ledermann, J.A.; Herd, R.; Maraninchi, D.; Viens, P.; Buclon, M.; Philip, T.; Cure, H.; Lotz, J.P.; Chauvin, F.; Ferrante, P.; Rosti, G., 2001:
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Hortobagyi, G.N., 2000:
High-dose chemotherapy for primary breast cancer: facts versus anecdotes

Mackall, C.L.; Helman, L.J., 2001:
High-dose chemotherapy for rhabdomyosarcoma: where do we go from here

Siegert, W.; Rick, O.; Beyer, J., 1999:
High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin

Burtness, B., 1999:
High-dose chemotherapy for the treatment of high-risk and advanced breast cancer

Tajima, T.; Ohta, M.; Tokuda, Y., 2000:
High-dose chemotherapy for treatment of breast cancers

Bay, J.O.; Blay, J.Y., 2001:
High-dose chemotherapy for tumor treatment: the end of the beginning ?

Charnay-Sonnek, F., 1999:
High-dose chemotherapy in a day clinic

Curé, H.; Bay, J.O.; Plagne, R.; Chollet, P.; Dauplat, J., 2001:
High-dose chemotherapy in advanced epithelial ovarian cancer

Schmid, P.; Possinger, K., 2002:
High-dose chemotherapy in breast cancer

Miller, K.D.; Sledge, G.W., 2000:
High-dose chemotherapy in breast cancer -- the perils of history uncontrolled

Rodenhuis, S., 2001:
High-dose chemotherapy in breast cancer--interpretation of the randomized trials

Antman, K.H., 2000:
High-dose chemotherapy in breast cancer: the end of the beginning?

Lelli, G., 2001:
High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows

Rick, O.; Beyer, J.; Kingreen, D.; Schwella, N.; Krusch, A.; Schleicher, J.; Kirsch, A.; Huhn, D.; Siegert, W., 1999:
High-dose chemotherapy in germ cell tumours: a large single centre experience

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J., 1998:
High-dose chemotherapy in gynecologic malignancies

Price, L.A., 1998:
High-dose chemotherapy in high-risk breast cancer

Rowlings, P.A., 1998:
High-dose chemotherapy in metastatic breast cancer

Leonard, R.C., 1998:
High-dose chemotherapy in metastatic breast cancer

Blay, J.Y.; Philip, T.O., 1996:
High-dose chemotherapy in non-Hodgkin's lymphoma

Espinosa Arranz, E.; González Barón, M., 2001:
High-dose chemotherapy in nonhematologic tumors

Lotz, J.P.; Lhommé, C.; Pautier, P.; Couteau, C.; Gligorov, J.; Alexandre, J.; Selle, F.; Izrael, V.; Maraninchi, D.; Viens, P., 2000:
High-dose chemotherapy in ovarian adenocarcinoma

Donato, M.L., 2002:
High-dose chemotherapy in ovarian cancer: still waiting for the right study

Herrin, V.E.; Thigpen, J.T., 1999:
High-dose chemotherapy in ovarian carcinoma

Bertuzzi, A.; Castagna, L.; Nozza, A.; Quagliuolo, V.; Siracusano, L.; Balzarotti, M.; Compasso, S.; Alloisio, M.; Soto Parra, H.; Santoro, A., 2002:
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study

Srinivas, S., 2000:
High-dose chemotherapy in poor-risk germ-cell tumors

Dupuis-Girod, S.; Hartmann, O.; Benhamou, E.; Doz, F.; Mechinaud, F.; Bouffet, E.; Coze, C.; Kalifa, C., 1997:
High-dose chemotherapy in relapse of medulloblastoma in young children

Pasini, F.; Durante, E.; D.M.nzoni, D.; Rosti, G.; Pelosi, G., 2003:
High-dose chemotherapy in small-cell lung cancer

Ray-Coquard, I.; Biron, P.; Blay, J.Y., 2001:
High-dose chemotherapy in soft tissue sarcomas of adults

Jense, T.S., 1996:
High-dose chemotherapy in solid tumors--a therapeutic breakthrough?

Hamilton, K.; Iskandar, B., 2018:
Amenorrhoea and reversible infertility due to obstructive hydrocephalus: literature review and case report

Kabícková, E.; Kavan, P.; Koutecký, J.; Malis, J.; Stanková, J.; Gajdos, P.; Kodet, R.; Cumlivská, E., 2001:
High-dose chemotherapy in the treatment of children with malignant lymphoma

Fagioli, F.; Aglietta, M.; Tienghi, A.; Ferrari, S.; Brach del Prever, A.; Vassallo, E.; Palmero, A.; Biasin, E.; Bacci, G.; Picci, P.; Madon, E., 2002:
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study

Crown, J.; Raptis, G.; Hamilton, N.; Hudis, C.; Vahclat, L.; Fennelly, D.; Norton, L., 1995:
High-dose chemotherapy of breast cancer

Antimi, M., 1998:
High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives

Crown, J., 1997:
High-dose chemotherapy of metastatic breast cancer: the end of the beginning?

Tartarone, A.; Aieta, M.; Morritti, M.G.; Palomba, G.; Romano, M.P.; Lelli, G., 1998:
High-dose chemotherapy of metastatic breast carcinoma

Heyll, A.; Söhngen, D.; Aul, C.; Schneider, P.; Kobbe, G.; Bauser, U.; Quenzel, E.M.; Schneider, W., 1998 :
High-dose chemotherapy of patients with multiple myeloma

Crown, J., 1995:
High-dose chemotherapy of solid tumours

Anonymous, 2002:
High-dose chemotherapy plus allogeneic stem cells to treat chronic lymphocytic leukemia or small lymphocytic lymphoma

Lippman, M.E., 2000:
High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer

Brodowicz, T.; Auerbach, L.; Zielinski, C., 2000:
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer

Kim, S.; Shiba, E.; Taguchi, T.; Kimoto, Y.; Inoue, T.; Shimazu, K.; Takamura, Y.; Tanji, Y.; Izukura, M.; Ogawa, H.; Sugiyama, H.; Kubota, T.; Kimura, T.; Takai, S., 1996:
High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer

Cameron, D.A.; Craig, J.; Gabra, H.; Lee, L.; MacKay, J.; Parker, A.C.; Leonard, R.C.; Anderson, E.; Anderson, T.; Chetty, U.; Dixon, M.; Hawkins, A.; Jack, W.; Kunkler, I.; Leonard, R.; Matheson, L.; Miller, W., 1996:
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group

Anand, A., 1993:
High-dose chemotherapy with autologous bone marrow support in node-positive melanoma

Aleĭnikova, O.V.; Strongin, I.S.; Pochetukhin, K.V., 2002:
High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations

Jost, L.M.; Honegger, H.P.; Stahel, R.A., 2000:
High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich

Basade, M.M.; Gulati, S.C., 1996:
High-dose chemotherapy with autologous bone marrow/stem-cell rescue in lung cancer

Gorczyńska, E.; Toporski, J.; Bogusławska-Jaworska, J.; Słociak, M., 1999:
High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results

Kochi; Ushio, 1999:
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors

Crump, M.; Gluck, S.; Pritchard, K.; Shepherd, L.; Pater, J., 1998:
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Akasaka, Y.; Madarame, J.; Yanada, S.; Igarashi, H.; Kuroda, A.; Nakata, J.; Ohishi, Y.; Kondou, N.; Tomita, M., 1998:
High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer

Yonemoto, T.; Tatezaki, S.; Ishii, T.; Satoh, T., 1999:
High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas

Yamane, T.; Hino, M.; Ohta, K.; Koh, K.R.; Nakamae, H.; Aoyama, Y.; Ota, T.; Kishida, T.; Mugitani, A.; Sannomiya, Y.; Kamitani, T.; Takubo, T.; Tatsumi, N., 2000:
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma

Uno, H.; Fujita, M.; Hino, N.; Nakagawa, H.; Miyagawa, H.; Aoki, J.; Taniyama, K.; Sasaki, N., 1999:
High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination

Dunkel, I.J., 2000:
High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors

Kortmann, R.D., 1998:
High-dose chemotherapy with autologous stem cell rescue in patients with recurrent and high-risk pediatric brain tumors

Dix, S.P.; Geller, R.B., 2000:
High-dose chemotherapy with autologous stem cell rescue in the outpatient setting

Ayash, L.J.; Elias, A.; Wheeler, C.; Tepler, I.; Schwartz, G.; Schnipper, L.; Frei, E.; Antman, K., 1993:
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience

Anonymous, 2000:
High-dose chemotherapy with autologous stem cell support in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma

Anonymous, 1998:
High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer

Anonymous, 1999:
High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer

Schrader, A.J.; Atzpodien, J., 2000:
High-dose chemotherapy with autologous stem-cell transplantation in patients with pretreated advanced malignant melanoma

Torello, E.; Koziner, B., 1993:
High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL

Namouni, F.; Doz, F.; Tanguy, M.L.; Quintana, E.; Michon, J.; Pacquement, H.; Bouffet, E.; Gentet, J.C.; Plantaz, D.; Lutz, P.; Vannier, J.P.; Validire, P.; Neuenschwander, S.; Desjardins, L.; Zucker, J.M., 1998:
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

Martín, M.; Casado, A.; Llorente, L.; López Martín, J.A.; Rodríguez Lescure, A.; Nieto, Y.; Ayala, F.; Pérez Calvo, J.; Alonso, J.L.; Pérez López, C.; Villegas, A.; Díaz-Rubio, E., 1998:
High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer

Bezwoda, W.R., 1998:
High-dose chemotherapy with haematopoietic rescue: application to primary management of metastatic breast cancer

Perey, L.; Leyvraz, S., 1995:
High-dose chemotherapy with hematopoietic salvage in patients with breast cancer

Takenaka, K.; Shinagawa, K.; Maeda, Y.; Makita, M.; Kozuka, T.; Ashiba, A.; Yamamoto, K.; Fujii, N.; Nawa, Y.; Hiramatsu, Y.; Sunami, K.; Ishimaru, F.; Yoshimo, T.; Kiura, K.; Harada, M., 2002:
High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas

Viens, P.; Maraninchi, D., 2001:
High-dose chemotherapy with hematopoietic stem-cell support in breast cancer

Montemurro, F.; Ueno, N.T.; Rondón, G.; Aglietta, M.; Champlin, R.E., 2002:
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends

Crown, J.P.; Fennelly, D., 1995:
High-dose chemotherapy with peripheral blood progenitor autografting

Nakagawa, S.; Miki, T.; Akaza, H.; Ozono, S.; Okano, T.; Sonoda, Y.; Tsukamoto, T.; Terachi, T.; Naito, K.; Naito, S.; Nishiyama, T.; Nonomura, N.; Hara, I.; Hoshi, S.; Yoshida, O., 2000:
High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group

Mukai, H.Y.; Kojima, H.; Suzukawa, K.; Hori, M.; Komeno, T.; Hasegawa, Y.; Ninomiya, H.; Mori, N.; Nagasawa, T., 1999:
High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma

Miyazaki, J.; Miyanaga, N.; Kawai, K.; Shimazui, T.; Takeshima, H.; Akaza, H., 2000:
High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer

Nishiyama, T.; Kishi, K.; Deguchi, T.; Mukaiyama, T.; Terunuma, M., 1996:
High-dose chemotherapy with peripheral blood stem-cell transplantation for hormone-refractory advanced carcinoma of the prostate: experience of two cases

Huang, H.; Huang, R.; Pan, L., 2002:
High-dose chemotherapy with peripheral-blood stem cells transplantation in patients with advanced gynecological malignant tumors

Protheroe, A.S.; Johnson, P.W., 1996:
High-dose chemotherapy with stem cell rescue for solid tumours

Rodenhuis, S.; de Vries, E.G., 1999:
High-dose chemotherapy with stem cell support for solid tumors in adults

McCauley, D.L., 1996:
High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer

Mayer, J., 1998:
High-dose chemotherapy--a new hope for some patients with malignant tumors?

MacNeil, M.; Eisenhauer, E.A., 1999:
High-dose chemotherapy: is it standard management for any common solid tumor?

Tayama, E.; Hayashida, N.; Fukunaga, S.; Tayama, K.; Takaseya, T.; Hiratsuka, R.; Aoyagi, S., 2002:
High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass

D.R., F.; Bohm, S.; Oriana, S.; Spatti, G.B.; Pirovano, C.; Tedeschi, M.; Zunino, F., 1993:
High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer

Lacava, J.A.; Ferreyra, R.; Leone, B.A.; Losada, C.; Elem, Y.L.; Vallejo, C.T., 1996:
High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx

Dann, E.J.; Anastasi, J.; Larson, R.A., 1998:
High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase

Anonymous, 1996:
High-dose clarithromycin should be avoided

Oelzner, P.; Kunze, A.; Henzgen, S.; Thoss, K.; Hein, G.; Stein, G.; Bräuer, R., 2000:
High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton

Ladenstein, R.; Lasset, C.; Hartmann, O.; Garaventa, A.; Philip, T., 1993:
High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. The European Group for Bone Marrow Transplantation

Hartman, J., 1997:
High-dose contrast media administration

Koudriavtseva, T.; Pozzilli, C.; D.B.asi, C.; Iannilli, M.; Trasimeni, G.; Gasperini, C.; Argentino, C.; Gualdi, G.F., 1996:
High-dose contrast-enhanced MRI in multiple sclerosis

Kitaichi, N.; Kotake, S.; Mizue, Y.; Sasamoto, Y.; Goda, C.; Iwabuchi, K.; Onoé, K.; Matsuda, H.; Nishihira, J., 2001:
High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease

Payne, D., 2000:
High-dose corticosteroids for asthma

Santini, G.; De Souza, C.; Congiu, A.M.; Nati, S.; Marino, G.; Soracco, M.; Sertoli, M.R.; Rubagotti, A.; Spriano, M.; Vassallo, F.; Rossi, E.; Vimercati, R.; Piaggio, G.; Figari, O.; Benvenuto, F.; Abate, M.; Truini, M.; Ravetti, J.L.; Ribizzi, I.; Damasio, E., 1999:
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow

Baldissera, R.C.; Aranha, J.F.P.; Oliveira, G.B.; Vigorito, A.C.; Eid, K.A.B.; Miranda, E.C.M.; D.S.uza, C.A., 2001:
High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma

Brodsky, R.A.; Jones, R.J., 2001:
High-dose cyclophosphamide in aplastic anaemia

Jaime-Pérez, J.C.; González-Llano, O.; Gómez-Almaguer, D., 2001:
High-dose cyclophosphamide in the treatment of severe aplastic anemia in children

Anonymous, 2001:
High-dose cyclophosphamide to treat severe aplastic anemia

Bingham, S.; Veale, D.; Fearon, U.; Isaacs, J.D.; Morgan, G.; Emery, P.; McGonagle, D.; Reece, R.; Clague, R.; Snowden, J.A., 2002:
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis

Petri, M.; Jones, R.J.; Brodsky, R.A., 2003 :
High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

Wheeler, C.; Eickhoff, C.; Elias, A.; Ibrahim, J.; Ayash, L.; McCauley, M.; Mauch, P.; Schwartz, G.; Eder, J.P.; Mazanet, R.; Ferrara, J.; Rimm, I.J.; Guinan, E.; Bierer, B.; Gilliland, G.; Churchill, W.H.; Ault, K.; Parsons, S.; Antman, K.; Schnipper, L.; Tepler, I.; Gaynes, L.; Frei, E.; Kadin, M.; Antin, J., 1997:
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes

Bisogno, G.; Cowie, F.; Boddy, A.; Thomas, H.D.; Dick, G.; Pinkerton, C.R., 1998:
High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours

Wang, W.S.; Tzeng, C.H.; Chiou, T.J.; Liu, J.H.; Fan, S.; Chen, P.M., 1996:
High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma

Schiller, G.; Emmanoulides, C.; Iastrebner, M.C.; Lee, M.; Naeim, F., 1996:
High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia

Shepherd, J.D.; Barnett, M.J.; Philips, G.L., 1996:
High-dose cytarabine induction for acute myeloid leukemia

Anonymous, 1999:
High-dose cytarabine produces high cure rate in some AML patients

Stein, A.S.; O'Donnell, M.R.; Slovak, M.L.; Nademanee, A.; Dagis, A.; Schmidt, G.M.; Parker, P.M.; Snyder, D.S.; Smith, E.P.; Somlo, G.; Margolin, K.A.; Arber, D.; Niland, J.; Forman, S.J., 2000:
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission

Whitlock, J.A.; Wells, R.J.; Hord, J.D.; Janco, R.L.; Greer, J.P.; Gay, J.C.; Edwards, J.R.; McCurley, T.L.; Lukens, J.N., 1997:
High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

Robertson, L.E.; Hall, R.; Keating, M.J.; Estey, E.; Kantarjian, H.M.; McLaughlin, P.; Hagemeister, F.B.; Plunkett, W., 1993:
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis

Cetkovská, P.; Pizinger, K.; Cetkovský, P., 2002:
High-dose cytosine arabinoside-induced cutaneous reactions

Douglas, J.T.; Shaw, J., 1997:
High-dose desmopressin in bleeding disorders

Sadikot, R.T.; Jansen, E.D.; Blackwell, T.R.; Zoia, O.; Yull, F.; Christman, J.W.; Blackwell, T.S., 2001:
High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice

Chandra, J., 1997:
High-dose dexamethasone for chronic/refractory immune thrombocytopenia

Schiavotto, C.; Ruggeri, M.; Castaman, G.; Rodeghiero, F., 1996:
High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura

Molica, S., 1994:
High-dose dexamethasone in refractory B-cell chronic lymphocytic leukemia patients

Godeau, B.; Bierling, P.; Oksenhendler, E.; Castaigne, S.; Deconinck, E.; Wechsler, B., 1996:
High-dose dexamethasone therapy for resistant autoimmune thrombocytopenic purpura

Hollander, D.; Pradas, J.; Kaplan, R.; McLeod, H.L.; Evans, W.E.; Munsat, T.L., 1994:
High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies

Kosty, M.P.; Herndon, J.E.; Vogelzang, N.J.; Kindler, H.L.; Green, M.R., 2001:
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631

Bertha, B.G.; Sill, J.C.; Berger, I.; Folts, J.D.; Milde, J.H., 1993:
High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets

Pisters, K.M.; Tyson, L.B.; Tong, W.; Fleisher, M.; Miller, V.A.; Grant, S.C.; Pfister, D.G.; Rigas, J.R.; Densmore, C.L.; Krol, G.; Heelan, R.T.; Sirotnak, F.M.; Bertino, J.R.; Kris, M.G., 1996:
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer

Escobar Sacristán, J.; de Granda Orive, J.I.; Gutiérrez Jiménez, T.; Martínez Albiach, J.M.; Fuentes Ramos, M.; Herrera de la Rosa, A., 1997:
High-dose endobronchial brachytherapy in malignant tumors of the lung

Manfredi, P.L.; Chandler, S.W.; Patt, R.; Payne, R., 1997:
High-dose epidural infusion of opioids for cancer pain: cost issues

Karch, S.B., 1993:
High-dose epinephrine

Mattana, J.; Singhal, P.C., 1993:
High-dose epinephrine in cardiopulmonary resuscitation

Frank, S.E., 1994:
High-dose epinephrine in cardiopulmonary resuscitation: are we missing the question?

Onat, H.; Basaran, M.; Esassolak, M.; Bavbek, S.E.; Anacak, Y.; Kaytan, E.; Altun, M.; Haydaroglu, A., 2003:
High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma

Cottu, P.H.; Zelek, L.; Extra, J.M.; Espie, M.; Mignot, L.; Morvan, F.; Marty, M., 1999:
High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients

Nielsen, O.S.; Dombernowsky, P.; Mouridsen, H.; Crowther, D.; Verweij, J.; Buesa, J.; Steward, W.; Daugaard, S.; van Glabbeke, M.; Kirkpatrick, A.; Tursz, T., 1998:
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

Kamata, K.; Sato, N.; Takahashi, E., 1993:
High-dose erythropoietin for unstable hemoglobin Burke in a patient receiving hemodialysis

Pivalizza, E.G.; Sweeney, M.S., 1997:
High-dose esmolol and cardiopulmonary bypass for mitral valve replacement in the beating heart

Pucci, G.; Irrera, G.; Martino, M.; Messina, G.; Console, G.; Morabito, F.; Iacopino, P., 1998:
High-dose etoposide enables the collection of peripheral blood stem cells in patients who failed cyclophosphamide-induced mobilization

Kohara, H.; Ueoka, H.; Tabata, M.; Shinagawa, K.; Hayashi, K.; Harada, M., 1998:
High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast

Kanfer, E.J.; McGuigan, D.; Samson, D.; Abboudi, Z.; Abrahamson, G.; Apperley, J.F.; Chilcott, S.; Craddock, C.; Davis, J.; MacDonald, C.; Macdonald, D.; Olavarria, E.; Philpott, N.; Rustin, G.J.; Seckl, M.J.; Sekhar, M.; Stern, S.; Newlands, E.S., 1998:
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels

Brown, R.A.; Wolff, S.N.; Fay, J.W.; Pineiro, L.; Collins, R.H.; Lynch, J.P.; Stevens, D.; Greer, J.; Herzig, R.H.; Herzig, G.P., 1996:
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group

Graham, D.Y., 1997:
High-dose famotidine for prevention of NSAID ulcers?

Morimoto, Y.; Morimoto, Y.; Bart, R.D.; Pearlstein, R.D.; Dexter, F.; Warner, D.S., 1997:
High-dose fentanyl does not adversely affect outcome from forebrain ischemia in the rat

Numai, T.; Inaba, H.; Mizuguchi, T., 1996:
High-dose fentanyl does not suppress interleukin-1 beta-induced increases in plasma ACTH and corticosterone in rats

Haubrich, R.H.; Haghighat, D.; Bozzette, S.A.; Tilles, J.; McCutchan, J.A., 1994:
High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group

Archer, B.R., 2002:
High-dose fluoroscopy: the administrator's responsibilities

Ruiz, Mín.; Vairo, C.; Matusevich, D.; Finkelsztein, C., 2002:
High-dose fluoxetine-induced mania. Review and case report

Mustacchi, G.; Pavesi, L.; Milani, S.; Iaffaioli, V.; Caraco, A.; Comella, G.; Contu, A.; Farris, A.; Attado-Parinello, G.; Narcisi, M., 1994:
High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial

D.C.stanzo, F.; Gasperoni, S.; Malacarne, P.; Belsanti, V.; Luppi, G.; Marzola, M.; Corgna, E.; Sdrobolini, A.; Passalacqua, R.; Figoli, F.; Algeri, R.; Zironi, S.; Angiona, S.; Boni, C., 1998:
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research

Louvet, C.; Beerblock, K.; de Gramont, A.; Varette, C.; Demuynck, B.; Bennamoun, M.; Cady, J.; Delfau, S.; Maisani, J.E.; Krulik, M., 1993 :
High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study

Waugh, J.B.; Op't Holt, T.B.; Gadek, J.E.; Clanton, T.L., 1996:
High-dose furosemide alters gas exchange in a model of acute lung injury

Lévy, P.; Perniceni, T.; Gayet, B., 1997:
High-dose furosemide: a new cause of chronic pancreatitis?

Kallmes, D.F.; Gray, L.; Glass, J.P., 1998:
High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases

Juneja, S.K.; Phillips, K.A.; Speed, B.; Januszewicz, E.H., 1996:
High-dose gamma-globulin responsive haemolysis due to cytomegalovirus in an immunocompetent adult

Bain, S.D.; Jensen, E.; Celino, D.L.; Bailey, M.C.; Lantry, M.M.; Edwards, M.W., 1993:
High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse

Aasen, A.O.; Svennevig, J.L., 1993:
High-dose glucocorticoids in surgery and trauma

Yokoya, S.; Araki, K.; Igarashi, Y.; Kohno, H.; Nishi, Y.; Hasegawa, Y.; Fujita, K.; Iwatani, N.; Tachibana, K.; Ohyama, Y.; Seino, Y.; Satoh, M.; Fujieda, K.; Tanaka, T., 1999:
High-dose growth hormone (GH) treatment in prepubertal GH-deficient children

de Zegher, F.; Maes, M.; Heinrichs, C.; Thiry, G.; D.C.ju, M.V.; D.S.hepper, J.; Craen, M.; Chanoine, J.P.; Dooms, L.; Malvaux, P., 1994:
High-dose growth hormone therapy for short children born small for gestational age. Belgian Study Group for Paediatric Endocrinology

Cipri, S.; Gangemi, A.; Campolo, C.; Cafarelli, F.; Gambardella, G., 1998:
High-dose heparin plus warfarin administration in non-traumatic dural sinuses thrombosis. A clinical and neuroradiological study

Porta, C.; Bobbio-Pallavicini, E., 1994:
High-dose human immunoglobulins in thrombotic thrombocytopenic purpura

Mehta, J.; Powles, R.; Singhal, S.; Swansbury, G.J.; Millar, B.; Shepherd, V.; Bell, J.; Min, T.; Cabral, S.; Treleaven, J., 1996:
High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results

Petzer, A.L.; Hochenburger, E.; Haun, M.; Duba, H.Ch.; Grünewald, K.; Hoflehner, E.; Sill, H.; Linkesch, W.; Gastl, Günther.; Gunsilius, E., 2002:
High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration

Pascual, J.; Cid, C.; Berciano, J., 1998:
High-dose i.v. immunoglobulin for peripheral neuropathy associated with Sjögren's syndrome

Verweij, J., 1998:
High-dose ifosfamide for soft tissue sarcomas: set the scene, or senescence?

Patel, S.R.; Vadhan-Raj, S.; Papadopolous, N.; Plager, C.; Burgess, M.A.; Hays, C.; Benjamin, R.S., 1997:
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

Vergnenègre, A.; Thomas, P.; Robinet, G.; Pibarot, M.; Paillotin, D.; Vernejoux, J.M.; Thiberville, L.; Lena, H.; Kleisbauer, J.P.; Gimonet, J.F., 2000:
High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)

Tursz, T., 1996:
High-dose ifosfamide in the treatment of advanced soft tissue sarcomas

Tiuliandin, S.A.; Liubimova, N.V.; Sidorova, N.I.; Averinova, S.G.; Kashkadaeva, A.V.; Romanova, L.F.; Shiriaev, S.V.; Garin, A.M., 1996:
High-dose ifosfamide in the treatment of patients with soft tissue sarcoma

D.P.s, T.; D.B.aud, F.; Orlando, L.; Nolè, F.; Munzone, E.; Zampino, M.G.; Fazio, N.; Aapro, M.S.; Goldhirsch, A., 1998:
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

Patel, S.R.; Forman, A.D.; Benjamin, R.S., 1994:
High-dose ifosfamide-induced exacerbation of peripheral neuropathy

Burt, R.K.; Traynor, A.; Oyama, Y.; Craig, R., 2002:
High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease

Rostoker, G.; Desvaux-Belghiti, D.; Pilatte, Y.; Petit-Phar, M.; Philippon, C.; Deforges, L.; Terzidis, H.; Intrator, L.; André, C.; Adnot, S.; Bonin, P.; Bierling, P.; Remy, P.; Lagrue, G.; Lang, P.; Weil, B., 1994:
High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura

Bodenstein, H., 1993:
High-dose immunoglobulin therapy of aplastic syndrome

Voit, T., 1993:
High-dose immunoglobulin treatment of epilepsy in children

Openshaw, H.; Nash, R.A.; McSweeney, P.A., 2002:
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review

McSweeney, P.A.; Furst, D.E.; West, S.G., 1999:
High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions

Heckmann, J.M.; LeePan, E.B.; Eastman, R.W., 2001:
High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up study

Wils, J.A., 1996:
High-dose infusional 5-FU in the treatment of advanced colorectal cancer: a summary of the European experience

Loeffler, T.M.; Hausamen, T.U., 1996:
High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer

Morgan, R.J.; Doroshow, J.H.; Venkataraman, K.; Chang, K.; Raschko, J.; Somlo, G.; Leong, L.; Tetef, M.; Shibata, S.; Hamasaki, V.; Margolin, K.; Forman, S.; Akman, S.; Coluzzi, P.; Ahn, C.; Weiss, L.; Gadgil, U.; Harrison, J., 1998:
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support

Zhang, M.; Nishimura, K.; Ikeda, A.; Tsukino, M.; Koyama, H.; Izumi, T., 1995:
High-dose inhaled beclomethasone dipropionate and maximal improvements in patients with stable chronic obstructive pulmonary disease

Kudo, K.; Tanabe, N.; Kabe, J., 1996:
High-dose inhaled beclomethasone in long-term management of chronic severe asthma--usefulness and dose-dependence

Lenney, W., 1996:
High-dose inhaled steroids in asthmatic children

Lipworth, B.J.; Clark, D., 1996:
High-dose inhaled steroids in asthmatic children

Pronzato, P.; Lionetto, R.; Botto, F.; Pensa, F.; Tognoni, A., 1998:
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study

Watson, A.R.; Bartlomé, P., 1994:
High-dose interferon alfa-2A for the treatment of chronic hepatitis C

Fontana, R.J.; Walsh, J.; Moyer, C.A.; Lok, A.S.F.; Webster, S.; Klein, S., 2002:
High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial

Bresci, G.; Parisi, G.; Bertoni, M.; Capria, A., 2001:
High-dose interferon plus ribavirin in chronic hepatitis C not responding to recombinant alpha-interferon

Bonkovsky, H.L.; Clifford, B.D.; Smith, L.J.; Allan, C.; Banner, B., 1996:
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial

Saiag, P., 1999:
High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?

Dutcher, J., 2002:
High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma

Wilson, W.R.; Siegel, R.S.; Harisiadis, L.A.; Davis, D.O.; Nguyen, H.H.; Bank, W.O., 2001:
High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck

Twardowski, Z.J., 1998:
High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters

Mitterhofer, A.P.; Antonelli, M.; Genuini, I.; Bertazzoni, G., 1998:
High-dose intranasal snorted heroin: a new cause of pancreatitis

Stacey, R.; Jones, R.; Kar, G.; Poon, A., 2001:
High-dose intrathecal diamorphine for analgesia after Caesarean section

Chaney, M.A., 1996:
High-dose intrathecal morphine for thoracoabdominal aneurysm repair

Tamakawa, S.; Iwanami, Y.; Ogawa, H., 1998:
High-dose intrathecal morphine to control cancer pain--a case report

Dill, C.; Shin, S., 2000:
High-dose intravenous benzodiazepine

Hermida-Rodriguez, C.; Cantero Perona, J.; Garcia-Valriberas, R.; Pajares Garcia, J.M.; Mate-Jimenez, J., 1999:
High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease

Honda, M.; Umeda, H.; Yoshida, K., 1998:
High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer

Moriguchi, H.; Yoshida, K.; Kitahara, S., 2000:
High-dose intravenous estrogen therapy

Sensky, P.R.; Olczak, S.A., 2000:
High-dose intravenous glucagon in severe tricyclic poisoning

Schneider, P.; Wehmeier, A.; Schneider, W., 1997:
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura

Sudo, K.; Tajima, Y.; Matsumoto, A., 2002:
High-dose intravenous immune globulin for stiff-person syndrome

Jolles, S., 2002:
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders

Nobile-Orazio, E.; Meucci, N., 2000:
High-dose intravenous immunoglobulin in multifocal motor neuropathy

Bassan, H.; Muhlbaur, B.; Tomer, A.; Spirer, Z., 1998:
High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis

Puppo, F., 2002:
High-dose intravenous immunoglobulin therapy for immune-mediated disorders. Only immunoglobulins?

Selcen, D.; Dabrowski, E.R.; Michon, A.M.; Nigro, M.A., 2000:
High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis

Rauova, L.; Lukac, J.; Levy, Y.; Rovensky, J.; Shoenfeld, Y., 2001:
High-dose intravenous immunoglobulins for lupus nephritis--a salvage immunomodulation

Rütter, A.; Luger, T.A., 2001:
High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin

Woodhouse, D., 1993:
High-dose intravenous infusions of Solu-Medrol for use in acute spinal cord injuries

Labar, D.R.; Ali, A.; Root, J., 1994:
High-dose intravenous lorazepam for the treatment of refractory status epilepticus

Griffin, T.C.; McIntire, D.; Buchanan, G.R., 1994:
High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease

Reed, J.B.; Morse, L.S.; Schwab, I.R., 1998:
High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis

Seppel, T.; Schlaghecke, R.; Becker, A.; Engelbrecht, V.; Feldkamp, J.; Kornely, E., 1996:
High-dose intravenous therapy with 7S immunoglobulins in autoimmune endocrine ophthalmopathy

Cochereau, I.; Diraison, M.C.; Mousalatti, H.; Bouyer, I.; Ren, L.; Guvenisik, N.; Hoang-Xuan, T., 2000:
High-dose intravitreal ganciclovir in CMV retinitis

Chen, M-Shan.; Li, J-Qing.; Zhang, Y-Qi.; Lu, L-Xia.; Zhang, W-Zhang.; Yuan, Y-Fei.; Guo, Y-Ping.; Lin, X-Jun.; Li, G-Hui., 2002:
High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma

Tarumi, Y.; Watanabe, S.; Bruera, E.; Ishitani, K., 2000:
High-dose ketamine in the management of cancer-related neuropathic pain

Cascinu, S.; Bichisao, E.; Amadori, D.; Silingardi, V.; Giordani, P.; Sansoni, E.; Luppi, G.; Catalano, V.; Agostinelli, R.; Catalano, G., 2000:
High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients

Anonymous, 2002:
High-dose lymphoablative therapy (HDLT) with or without autologous stem-cell rescue for treatment of severe autoimmune diseases

Aksu, F.; Madazli, R.; Budak, E.; Cepni, I.; Benian, A., 1997:
High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents

Popov, I.; Jelić, S.; Milanović, N.; Kovcin, V.; Vuletić, L., 1996:
High-dose medroxyprogesterone acetate in the treatment of metastatic carcinoma of renal parenchyma

Moreau, P.; Milpied, N.; de Faucal, P.; Petit, T.; Herbouiller, P.; Bataille, R.; Harousseau, J.L., 1996:
High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement

Moreau, P.; Bataille, R.; Mahé, B.; Milpied, N.; Harousseau, J.L., 1993:
High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma

Rives, S.; Bladé, J.; Martínez, C.; Marín, P.; Carreras, E.; Montserrat, E., 2000:
High-dose melphalan treatment followed by hematopoietic progenitor cell rescue in primary amyloidosis

Hjorth, M.; Lenhoff, S.; Turesson, I.; Westin, J., 2000:
High-dose melphalan with stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective

Philip, T.; Iliescu, C.; Demaille, M.C.; Pacquement, H.; Gentet, J.C.; Krakowski, I.; Soler-Michel, P.; Thiesse, P.; Chauvin, F.; Blay, J.Y.; Brunat-Mentigny, M., 1999:
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique

Brain, E.; Alexandre, J.; Minozzi, C.; Misset, J.L., 1997:
High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis

Shamash, J.; Joel, S.; Lundholm, L.; Millard, L.; Oliver, T., 2002:
High-dose methotrexate clearance following prior vancomycin administration: no significant interaction in the absence of overt renal impairment

Batchelor, T.; Leahy, N.; Kaufman, D., 2001:
High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma

Ng, S.; Rosenthal, M.A.; Ashley, D.; Cher, L., 2001:
High-dose methotrexate for primary CNS lymphoma in the elderly

Chowbay, B.; Siong, K.K., 2002:
High-dose methotrexate in fibroblastic osteosarcoma

Cole, P.D.; Kamen, B.A., 2000:
High-dose methotrexate is lethal to rats. Why give it to children?

Kamen, B.A.; Weitman, S.D., 1994:
High-dose methotrexate: is it warranted?

Chakrabarti, S.; Behera, D.; Varma, S.; Bambery, P., 1997:
High-dose methyl prednisolone for autoimmune thrombocytopenia in sarcoidosis

Nayduch, D.; Lee, A.; Butler, D., 1994:
High-dose methylprednisolone after acute spinal cord injury

Gurgey, A.; Sayli, T.; Gunay, M.; Ersoy, F.; Kucukali, T.; Kale, G.; Caglar, M., 1994:
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement

Hugenholtz, H.; Cass, D.E.; Dvorak, M.F.; Fewer, D.H.; Fox, R.J.; Izukawa, D.M.S.; Lexchin, J.; Tuli, S.; Bharatwal, N.; Short, C., 2002:
High-dose methylprednisolone for acute closed spinal cord injury--only a treatment option

Hi[csönmez, G.; Ozsoylu, S.; Onat, N.; Prozorova, Z.V.; Gümrük, F.; Tuncer, M., 1994:
High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia

Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V., 1993:
High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up

Pettersson, K.; Toolanen, G., 1998:
High-dose methylprednisolone prevents extensive sick leave after whiplash injury. A prospective, randomized, double-blind study

Kurata, H.; Yamazaki, I.; Ishii, M.; Yano, Y.; Kase, M.; Tomiyama, I., 1997:
High-dose methylprednisolone pulse therapy for respiratory failure after open heart surgery

Dufour, A.; Salmaggi, A.; L.M.ntia, L.; Eoli, M.; Nespolo, A.; Milanese, C., 1994:
High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients

Suda, T.; Sugimura, S.; Hattori, Y.; Sugimura, H.; Kobayashi, Y.; Hoshino, R., 1998:
High-dose methylprednisolone-containing chemotherapy in advanced invasive thymoma--report of three cases

Yetgin, S.; Ozbek, N., 1997:
High-dose methylprednisolone-induced dramatic maturation of granulocytes in idiopathic chronic neutropenia

Oldhafer, K.J.; Frerker, M.K.; Lang, H.; Fauler, J.; Flemming, P.; Schmoll, E.; Nadalin, S.; Moreno, L.; Pichlmayr, R., 1999:
High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastases

Tarella, C.; Zallio, F.; Caracciolo, D.; Cuttica, A.; Corradini, P.; Gavarotti, P.; Ladetto, M.; Podio, V.; Sargiotto, A.; Rossi, G.; Gianni, A.M.; Pileri, A., 2001:
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

Feldman, E.J., 1998:
High-dose mitoxantrone in acute leukaemia: New York Medical College experience

Grevelhörster, T.; Micke, O.; Hampel, G.; Schönekaes, K.; Willich, N., 1996:
High-dose multimodal radiotherapy of confluent destructively growing aggregated keratoacanthoma. 2 case reports

Marrazzi, M.A.; Wroblewski, J.M.; Kinzie, J.; Luby, E.D., 1997:
High-dose naltrexone and liver function safety

Schumann, R.E.; Swindle, M.M.; Knick, B.J.; Case, C.L.; Gillette, P.C., 1994:
High-dose narcotic anesthesia using sufentanil in swine for cardiac catheterization and electrophysiologic studies

Komatsu, M.; Suto, T.; Ishikawa, K.; Sato, S., 1999:
High-dose natural interferon-alpha therapy for chronic hepatitis C with a high viral load: predictors of efficacy. The Aomori, Akita and Iwate Areas Viral Hepatitis Research Group

Fleishman, M., 1994:
High-dose neuroleptics

Guglina, M.E., 1997:
High-dose nitroglycerin in cardiogenic shock

Sheitman, B.B.; Lindgren, J.C.; Early, J.; Sved, M., 1997:
High-dose olanzapine for treatment-refractory schizophrenia

Heimann, S.W., 1999:
High-dose olanzapine in an adolescent

Van Biervliet, S.; Van Winckel, M.; Robberecht, E.; Kerremans, I., 2001:
High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia

Friedel, D.; Ozick, L.A., 1998:
High-dose omeprazole in patients with noncardiac chest pain

Busam, J.; Garbe, W.E., 1994:
High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison

Paice, J.A., 2002:
High-dose opioids may manage neuropathic pain

Korones, D.N., 1996:
High-dose oral dexamethasone therapy in idiopathic thrombocytopenic purpura

Castagnola, E.; Cristina, E.; Dufour, C., 2002:
High-dose oral ganciclovir for management of CMV-symptomatic infection in a child with acute lymphoblastic leukemia

Ramin, K.D.; Ogburn, P.L.; Danilenko, D.R.; Ramsey, P.S., 2003:
High-dose oral misoprostol for mid-trimester pregnancy interruption

Radbruch, L.; Grond, S.; Zech, D.J.; Bischoff, A., 1996:
High-dose oral morphine in cancer pain management: a report of twelve cases

Anonymous, 2002:
High-dose oxygen during surgery cuts infection rates

Dombrowski, M.P.; Bottoms, S.F., 1996:
High-dose oxytocin

Vogelzang, N.J.; Herndon, J.E.; Miller, A.; Strauss, G.; Clamon, G.; Stewart, F.M.; Aisner, J.; Lyss, A.; Cooper, M.R.; Suzuki, Y.; Green, M.R., 1999:
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234

Elgindy, N.; Lindholm, H.; Gunvén, P., 2000:
High-dose percutaneous ethanol injection therapy of liver tumors. Patient acceptance and complications

Facca, A.; Sanchez-Ramos, J., 1996:
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias

Trivedi, H.L.; Shah, V.R.; Vanikar, A.V.; Gera, D.; Shah, P.R.; Trivedi, V.B.; Khemchandani, S.; Mehta, A.; Dalal, S.S.; Shah, S.A.; Shah, T.P.; Visana, K.V., 2002:
High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients

Gorins, A., 1993:
High-dose progestational contraception: side effects

Maltoni, M.; Nanni, O.; Scarpi, E.; Rossi, D.; Serra, P.; Amadori, D., 2001:
High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials

Friedli, A.; Salomon, D.; Saurat, J.H., 2001:
High-dose pulse corticosteroid therapy: is it indicated for severe alopecia areata?

Demiroğlu, H.; Dündar, S., 1997:
High-dose pulsed dexamethasone for immune thrombocytopenia

Willers, H.; Würschmidt, F.; Bünemann, H.; Heilmann, H.P., 1998:
High-dose radiation therapy alone for inoperable non-small cell lung cancer--experience with prolonged overall treatment times

Peiffert, D.; Giovannini, M.; Ducreux, M.; Michel, P.; François, E.; Lemanski, C.; Mirabel, X.; Cvitkovic, F.; Luporsi, E.; Conroy, T.; Gérard, J.P., 2001:
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study

Hayakawa, K.; Mitsuhashi, N.; Katano, S.; Saito, Y.; Nakayama, Y.; Sakurai, H.; Akimoto, T.; Hasegawa, M.; Yamakawa, M.; Niibe, H., 2001 :
High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer

Press, O.W.; Eary, J.; Badger, C.C.; Appelbaum, F.R.; Wiseman, G.; Matthews, D.; Martin, P.J.; Bernstein, I.D., 1993:
High-dose radioimmunotherapy of lymphomas

Cetin, L.; Yilmaz, E.; Alpsoy, E.; Başaran, E., 1998:
High-dose ranitidine is ineffective in the treatment of psoriasis

Inoue, K.; Kasahara, K.; Karashima, T.; Inoue, Y.; Kariya, S.; Inomata, T.; Yoshida, S.; Shuin, T., 2001:
High-dose rate Iridium-192 brachytherapy with flexible applicator--a trial toward decrease of stress during treatment and improvement of quality of life

Muto, P.; Ravo, V.; Panelli, G.; Liguori, G.; Fraioli, G., 2000:
High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy

Böhmer, D.; Deger, S.; Dinges, S.; Schnorr, D.; Loening, S.A.; Budach, V., 2002:
High-dose rate brachytherapy--the Charité experience

Taulelle, M.; Chauvet, B.; Vincent, P.; Félix-Faure, C.; Bucciarelli, B.; Garcia, R.; Reboul, F., 1996:
High-dose rate endobronchial brachytherapy: results and complications in 189 patients

Inoue, T.; Inoue, T., 2000:
High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue

Inoue, T.; Inoue, T.; Yoshioka, Y.; Yoshida, K., 2000:
High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue

Chatani, M.; Matayoshi, Y.; Masaki, N.; Inoue, T., 1997:
High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation

Teshima, T.; Inoue, T.; Inoue, T.; Ikeda, H.; Sasaki, S.; Yamazaki, H.; Ohtani, M.; Murayama, S.; Kozuka, T., 1993:
High-dose rate intracavitary therapy for cervical cancer with a microSelectron: a preliminary report

Merchant, T.E.; Zelefsky, M.J.; Sheldon, J.M.; LaQuaglia, M.B.; Harrison, L.B., 1997:
High-dose rate intraoperative radiation therapy for pediatric solid tumors

Kasahara, K.; Inoue, K.; Karashima, T.; Inoue, Y.; Kariya, S.; Inomata, T.; Yoshida, S.; Shuin, T., 2001:
High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer

Deger, S.; Dinges, S.; Roigas, J.; Schnorr, D.; Turk, I.; Budach, V.; Hinkelbein, W.; Loening, S.A., 1997:
High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer

Tagliaferri, P.; Correale, P.; Mottola, M.; de Simone, G.; Montesarchio, V.; Matano, E.; Rea, A.; Morabito, A.; Famiani, M.; Ciardiello, F.; Tortora, G.; Caraglia, M.; Barile, C.; Palmieri, G.; Bianco, A.R., 1996:
High-dose recombinant interleukin-2/verapamil combination in advanced cancer

Mattimoe, D.; Newton, W., 1998:
High-dose riboflavin for migraine prophylaxis

Kellner, C.H., 2000:
High-dose right unilateral ECT

Keating, M.; O'Brien, S., 2001:
High-dose rituximab therapy in chronic lymphocytic leukemia

Franzius, C.; Schuck, A.; Bielack, S.S., 2002:
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

Paredes, R.; Puig, T.; Arnó, A.; Negredo, E.; Balagué, M.; Bonjoch, A.; Jou, A.; Tuldrà, A.; Tural, C.; Sirera, G.; Veny, A.; Romeu, J.; Ruiz, L.; Clotet, B., 2000:
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response

Tarella, C.; Cuttica, A.; Caracciolo, D.; Zallio, F.; Ricca, I.; Bergui, L.; Gavarotti, P.; Marinone, C.; Pagano, M.; Rossi, G.; de Crescenzo, A.; Salomone, A.; Ladetto, M.; Boccadoro, M.; Pileri, A., 2002:
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments

Sanna, P.; Van den Bosch, S.; Cavalli, F.; Ghielmini, M., 1999:
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma

Lüftjohann, D.; Sigit, J.I.; Locatelli, S.; von Bergmann, K.; Schmidt, H.H., 2001:
High-dose simvastin (80 mg/day) decreases plasma concentrations of total homocyst(e)ine in patients with hypercholesteromia

Asada, Y.; Suzuki, H.; Nakabayashi, S.; Furukawa, M., 1998:
High-dose steroid therapy for sudden deafness--efficacy in severe cases

Ellis, M.F., 1993:
High-dose steroid therapy offers improvement in spinal cord injuries

Theiss, W.; Busch, U.; Renner, U.; Blömer, H., 1996:
High-dose streptokinase therapy with three million units in one hour significantly improves early coronary patency rates in acute myocardial infarction

Commissaris, R.L.; Hill, T.J., 1994:
High-dose subchronic imipramine treatment: effects on anxiety-like (conflict) behavior in rats

Martinez, A.E.; Atherton, D.J., 2000:
High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme

Sakuma, Y.; Uchida, H.; Nagai, H.; Kobayashi, E., 2001:
High-dose tacrolimus and lengthy survival of the combined rat pancreas/spleen graft in a high-responder combination

Armitage, 2001:
High-dose therapy and ABMT for follicular lymphoma

Fleury, J.; Legros, M.; Colombat, P.; Cure, H.; Travade, P.; Tortochaux, J.; Dionet, C.; Chollet, P.; Linassier, C.; Lamagnere, J.P.; Blaise, D.; Viens, P.; Maraninchi, D.; Plagne, R., 1996:
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease

Frankovich, J.; Donaldson, S.S.; Lee, Y.; Wong, R.M.; Amylon, M.; Verneris, M.R., 2001:
High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes

Cao, T.M.; Horning, S.; Negrin, R.S.; Hu, W.W.; Johnston, L.J.; Taylor, T.L.; Shizuru, J.A.; Hoppe, R.T.; Brown, B.W.; Blume, K.G.; Stockerl-Goldstein, K.E., 2001:
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience

Sweetenham, J.W.; Carella, A.M.; Taghipour, G.; Cunningham, D.; Marcus, R.; Della Volpe, A.; Linch, D.C.; Schmitz, N.; Goldstone, A.H., 1999:
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party

Dowling, A.J.; Prince, H.M.; Wirth, A.; Wolf, M.; Januszewicz, E.H.; Juneja, S.; Seymour, J.F.; Gates, P.; Smith, J.G., 2001:
High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience

Majolino, I.; Marcenò, R.; Pecoraro, G.; Scimé, R.; Vasta, S.; Liberti, G.; Rizzo, A.; Indovina, A.; Caronia, F., 1993:
High-dose therapy and autologous transplantation in amyloidosis-AL

Lotz, J.P.; Pene, F.; Bouleuc, C.; André, T.; Gligorov, J.; Avenin, D.; Esteso, A.; Bellaiche, A.; Macovei, C.; Merad, Z.; Laadem, A.; Vanica, R.; Izrael, V., 1996:
High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors

Barlogie, B.; Shaughnessy, J.; Zangari, M.; Tricot, G., 2003:
High-dose therapy and immunomodulatory drugs in multiple myeloma

Kitajima, H.; Nasu, K.; Tsudo, M.; Fujimoto, M.; Hayashi, K.; Ohno, H.; Konaka, Y.; Katsurada, T.; Arima, N.; Doi, S.; Moriguchi, T.; Fukuhara, S., 2001:
High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study

Federico, M.; Clò, V.; Carella, A.M., 1996:
High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial

Koh, L.P.; Linn, Y.C.; Teoh, G.; Goh, Y.T.; Tan, P.H.C., 2003:
High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma

Haioun, C.; Lepage, E.; Gisselbrecht, C.; Coiffier, B.; Doyen, C.; Morel, P.; Attal, M.; Tilly, H.; Deconinck, E.; Gaulard, P.; Reyes, F., 1998:
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

Linch, D.C.; Goldstone, A.H., 1999:
High-dose therapy for Hodgkin's disease

Pettengell, R., 1996:
High-dose therapy for aggressive non-Hodgkin's lymphoma

Perry, A.R.; Goldstone, A.H., 1998:
High-dose therapy for diffuse large-cell lymphoma in first remission

Freedman, A.; Friedberg, J.W.; Gribben, J., 2000:
High-dose therapy for follicular lymphoma

Anderson-Reitz, L.; Mechling, B.E.; Hertz, S.L., 1999:
High-dose therapy for treatment of breast cancer

Carlo-Stella, C.; Mangoni, L.; Caramatti, C.; Almici, C.; Rizzoli, V., 1998:
High-dose therapy in acute leukemia

Caballero, M.D.; Pérez-Simón, J.A.; Iriondo, A.; Lahuerta, J.J.; Sierra, J.; Marín, J.; Gandarillas, M.; Arranz, R.; Zuazu, J.; Rubio, V.; Fernández de Sevilla, A.; Carreras, E.; García-Conde, J.; García-Laraña, J.; Grande, C.; Sureda, A.; Vidal, M.J.; Rifón, J.; Pérez-Equiza, C.; Varela, R.; Moraleda, J.M.; García Ruíz, J.C.; Albó, C.; Cabrera, R.; San Miguel, J.F.; Conde, E., 2002:
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group

Mink, S.A.; Armitage, J.O., 2001:
High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma

Samson, D., 1996:
High-dose therapy in multiple myeloma

Patriarca, F.; Damiani, D.; Fanin, R.; Grimaz, S.; Geromin, A.; Cerno, M.; Sperotto, A.; Silvestri, F.; Zaja, F.; Baccarani, M., 2000:
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome

Lyttelton, M.P.; Newlands, E.S.; Giles, C.; Bower, M.; Guimaraes, A.; O'Reilly, S.; Rustin, G.J.; Samson, D.; Kanfer, E.J., 1998:
High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors

Kvalheim, G.; Pharo, A.; Holte, H.; Jakobsen, E.; Erikstein, B.; Kvaløy, S.; Beiske, K.; Nesland, J.M.; Smeland, E.B., 1996:
High-dose therapy of cancer with CD34 positive cells as stem cell support

Mareschová, I., 1997:
High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W"

Tempero, M.; Leichner, P.; Baranowska-Kortylewicz, J.; Harrison, K.; Augustine, S.; Schlom, J.; Anderson, J.; Wisecarver, J.; Colcher, D., 2000:
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial

Foran, J.M.; Apostolidis, J.; Papamichael, D.; Norton, A.J.; Matthews, J.; Amess, J.A.; Lister, T.A.; Rohatiner, A.Z., 1998:
High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre

Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J., 1994:
High-dose therapy with autologous stem cell support in malignant diseases

Kolstad, A.; Holte, H.; Kvaløy, S.; Jakobsen, E.; Erikstein, B.; Aurlien, E.; Kvalheim, G.; Bøhler, P.J.; Langholm, R., 1996:
High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood

Brice, P.; Simon, D.; Bouabdallah, R.; Bélanger, C.; Haïoun, C.; Thieblemont, C.; Tilly, H.; Harousseau, J.L.; Doyen, C.; Martin, C.; Brousse, N.; Solal-Céligny, P.H., 2001:
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol

Verdonck, L.F., 2000:
High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma

Matheson, I., 1996:
High-dose therapy with cytostatic agents as primary treatment of advanced breast cancer

Duswald, K.H.; Penk, A.; Pittrow, L., 1998:
High-dose therapy with fluconazole > or = 800 mg day-1

Penk, A.; Pittrow, L., 1997:
High-dose therapy with fluconazole > or = 800 mg/day. Review

Alvarnas, J.C.; Negrin, R.S.; Horning, S.J.; Hu, W.W.; Long, G.D.; Schriber, J.R.; Stockerl-Goldstein, K.; Tierney, K.; Wong, R.; Blume, K.G.; Chao, N.J., 2000:
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma

Tempero, M.; Leichner, P.; Dalrymple, G.; Harrison, K.; Augustine, S.; Schlam, J.; Anderson, J.; Wisecarver, J.; Colcher, D., 1997:
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial

Goldschmidt, H.; Hegenbart, U.; Wallmeier, M.; Hohaus, S.; Engenhart, R.; Wannenmacher, M.; Haas, R., 1997:
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

Müngersdorf, M.; Sommer, U.; Sommer, M.; Reichmann, H., 2002:
High-dose therapy with ropinirole in patients with Parkinson's disease

Chen, A.R., 1999:
High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results

Nylenna, M.; Haug, C.; Bjørndal, A., 1996:
High-dose therapy with stem cell support and support by a cabinet minister

Winter, J.N., 2000:
High-dose therapy with stem-cell transplantation in the malignant lymphomas

Canellos, G.P., 1994:
High-dose therapy: here to stay or just visiting?

Chopra, R., 1994:
High-dose therapy: the Third UCH Meeting

Bengala, C.; Pazzagli, I.; Innocenti, F.; Donati, S.; Favre, C.; Menconi, M.C.; Greco, F.; Danesi, R.; Orlandini, C.; Guarneri, V.; Del Tacca, M.; Conte, P.F., 2001:
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)

Izhogin, D.G.; Boiarshinov, V.K.; Dolgonolov, I.S.; Iankelevich, M.Ia.; Ptushkina, E.A.; Mentkevich, G.L., 2001:
High-dose thiotepa chemotherapy in children

Haley, E.C., 1998:
High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS II Investigators

Rowinsky, E.K.; Baker, S.D.; Burks, K.; O'Reilly, S.; Donehower, R.C.; Grochow, L.B., 1998:
High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study

Gershanovich, M.; Hayes, D.F.; Ellmén, J.; Vuorinen, J., 1997:
High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer

Grond, S.; Radbruch, L.; Meuser, T.; Loick, G.; Sabatowski, R.; Lehmann, K.A., 1999:
High-dose tramadol in comparison to low-dose morphine for cancer pain relief

Cizza, G.; Gold, P.W.; Chrousos, G.P., 1997:
High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression

Rohatiner, A.Z.; Bassan, R.; Raimondi, R.; Amess, J.A.; Arnott, S.; Personen, A.; Rodeghiero, F.; Barbui, T.; Bradburn, M.J.; Carter, M.; Lister, T.A., 2000:
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia

Rohatiner, A.Z.S., 2002:
High-dose treatment with autologous haemopoietic progenitor cell support for large B-cell, follicular and mantle-cell lymphoma

Siegert, W.; Beyer, J.; Strohscheer, I.; Baurmann, H.; Oettle, H.; Zingsem, J.; Zimmermann, R.; Bokemeyer, C.; Schmoll, H.J.; Huhn, D., 1994:
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

Eriksson, B.; Renstrup, J.; Imam, H.; Oberg, K., 1997:
High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects

Hum, M.; Holcenberg, J.S.; Tkaczewski, I.; Weaver, J.W.; Wilson, J.; Kamen, B.A., 1998:
High-dose trimetrexate and minimal-dose leucovorin: a case for selective protection?

Krutmann, J., 1997:
High-dose ultraviolet A1 (UVA1) phototherapy: does it work?

Giacoia, G.P., 1993:
High-dose urokinase therapy in newborn infants with major vessel thrombosis

Harnois, D.M.; Angulo, P.; Jorgensen, R.A.; Larusso, N.F.; Lindor, K.D., 2001:
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

Anonymous, 2001:
High-dose valaciclovir linked to problems

D.F.lippo, A.; Grechi, S.; Rizzo, L.; Benvenuti, S.; Novelli, G.P., 1995:
High-dose vecuronium in "open-eye" emergency surgery

Gokel, Y.; Paydas, S.; Duru, M., 2000:
High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure

Beyer, J.; Stenning, S.; Gerl, A.; Fossa, S.; Siegert, W., 2002:
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis

Hiddemann, W.; Aul, C.; Maschmeyer, G.; Schönrock-Nabulsi, R.; Ludwig, W.D.; Bartholomäus, A.; Bettelheim, P.; Becker, K.; Balleisen, L.; Lathan, B., 1993:
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison

Tzaneva, S.; Seeber, A.; Schwaiger, M.; Hönigsmann, H.; Tanew, A., 2001:
High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis

Berry, D.A.; Broadwater, G.; Klein, J.P.; Antman, K.; Aisner, J.; Bitran, J.; Costanza, M.; Freytes, C.O.; Stadtmauer, E.; Gale, R.Peter.; Henderson, I.Craig.; Lazarus, H.M.; McCarthy, P.L.; Norton, L.; Parnes, H.; Pecora, A.; Perry, M.C.; Rowlings, P.; Spitzer, G.; Horowitz, M.M., 2002:
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

Branch, D.R., 1999 :
High-dose vitamin C supplementation increases plasma glucose

Graphakos, S.; Goussetis, E.; Peristeri, J.; Kitra, V.; Papadakis, V.; Aroni, S., 1996:
High-dose, continuous r-TPA infusion for treatment of VOD

Leborgne, F.; Leborgne, J.H.; Zubizarreta, E.; Fowler, J.F.; Maisonneuve, J.; Ferrari, D.; Curochquin, R., 2002:
High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model

Micheletti, E.; La Face, B.; Feroldi, P.; Galelli, M.; Buttolo, L.; Stefini, R.; Giunta, F., 1996:
High-dose-rate brachytherapy for poor-prognosis, high-grade glioma: (phase II) preliminary results

Rudoltz, M.S.; Perkins, R.S.; Luthmann, R.W.; Fracke, T.D.; Green, T.M.; Moye, L.; Wludyka, P.; Choi, Y.K.; Ackerman, S.N., 1999:
High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx

Tyree, W.C.; Cardenes, H.; Randall, M.; Papiez, L., 2002:
High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications

Gava, A.; Fontan, L.; Bolner, A.; Botturi, M.; Cafaro, I.; D.M.rco, A.; Marazzato, G.; Muto, P.; Orecchia, R.; Orsatti, M.; Parisi, S.S.; Rigon, A., 1996:
High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience

MacLeod, C.; Fowler, A.; Dalrymple, C.; D'Costa, I.; Firth, I.; Atkinson, K.; Elliot, P.; Carter, J., 1997:
High-dose-rate brachytherapy in the management of carcinoma of the cervix: an 8-year Australian experience

Syed, A.M.; Puthawala, A.; Sharma, A.; Gamie, S.; Londrc, A.; Cherlow, J.M.; Damore, S.J.; Nazmy, N.; Sheikh, K.M.; Ko, S.J., 2002:
High-dose-rate brachytherapy in the treatment of carcinoma of the prostate

Glatzel, M.; Büntzel, J.; Schröder, D.; Küttner, K.; Fröhlich, D., 2002:
High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer

Orecchia, R.; Ragona, R.; Anglesio, S.; Tessa, M.; Del Mastro, E.; Sannazzari, G.L., 1996:
High-dose-rate brachytherapy. The indications, technic and preliminary results

Solomonov, A.; Rosenblatt, E.; Ben-Izhak, O.; Goralnik, L.; Yigla, M., 2001:
High-dose-rate endobronchial brachytherapy in endobronchial metastatic malignant chondroid syringoma

Hu, K.S.; Enker, W.E.; Harrison, L.B., 2002:
High-dose-rate intraoperative irradiation: current status and future directions

Cengiz, M.; Ozyar, E.; Ersu, B.; Akyol, F.H.; Atahan, I.L., 1999:
High-dose-rate mold brachytherapy of early gingival carcinoma: a clinical report

Lu, J.J.; Bains, Y.S.; Abdel-Wahab, M.; Brandon, A.H.; Wolfson, A.H.; Raub, W.A.; Wilkinson, C.M.; Markoe, A.M., 2002:
High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma

Petereit, D.G.; Sarkaria, J.N.; Potter, D.M.; Schink, J.C., 1999:
High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience

Bosch, T.; Lennertz, A.; Samtleben, W., 2002:
High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report

Li, M.; Xu, H.; Chen, C-Qing., 2002:
High-efficiency Expression of Prolyl Endopeptidase from Aeromonas punctata subsp. Punctata in Escherichia coli

Bielefeldt-Ohmann, H.; Fitzpatrick, D.R., 1998:
High-efficiency T-vector cloning of PCR products by forced A tagging and post-ligation restriction enzyme digestion

Afonin, A.G.; Baranov, V.T.; Biryukov, V.M.; Breese, M.B.; Chepegin, V.N.; Chesnokov, Y.A.; Guidi, V.; Ivanov, Y.M.; Kotov, V.I.; Martinelli, G.; Scandale, W.; Stefancich, M.; Terekhov, V.I.; Trbojevic, D.; Troyanov, E.F.; Vincenzi, D., 2001:
High-efficiency beam extraction and collimation using channeling in very short bent crystals

Schächter, 1995:
High-efficiency beam-wave interaction in quasiperiodic structures

Shiono, T.; Hamamoto, T.; Takahara, K., 2002:
High-efficiency blazed diffractive optical elements for the violet wavelength fabricated by electron-beam lithography

Shen, Y.; Berger, S.J.; Anderson, G.A.; Smith, R.D., 2000:
High-efficiency capillary isoelectric focusing of peptides

Seki, M.; Carninci, P.; Nishiyama, Y.; Hayashizaki, Y.; Shinozaki, K., 1998:
High-efficiency cloning of Arabidopsis full-length cDNA by biotinylated CAP trapper

Seidel; Titkov; André; Voisin; Voos, 1994:
High-efficiency energy up-conversion by an "Auger fountain" at an InP-AlInAs type-II heterojunction

Orzechowski; Anderson; Clark; Fawley; Paul; Prosnitz; Scharlemann; Yarema; Hopkins; Sessler; Wurtele, 1986:
High-efficiency extraction of microwave radiation from a tapered-wiggler free-electron laser

Ivanchenko, 1996:
High-efficiency frequency generation in a periodic array of Josephson junctions

Horwood, N.J.; Smith, C.; Andreakos, E.; Quattrocchi, E.; Brennan, F.M.; Feldmann, M.; Foxwell, B.M.J., 2002:
High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets

Zhou, P.; Lee, J.; Moore, P.; Brasky, K.M., 2001:
High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression

Bayle, J.Y.; Johnson, L.G.; S.G.orge, J.A.; Boucher, R.C.; Olsen, J.C., 1993:
High-efficiency gene transfer to primary monkey airway epithelial cells with retrovirus vectors using the gibbon ape leukemia virus receptor

Brooks, B.; Phillips, R.S.; Benisek, W.F., 1998:
High-efficiency incorporation in vivo of tyrosine analogues with altered hydroxyl acidity in place of the catalytic tyrosine-14 of Delta 5-3-ketosteroid isomerase of Comamonas (Pseudomonas) testosteroni: effects of the modifications on isomerase kinetics

Cho, H.J.; Farrand, S.K.; Noel, G.R.; Widholm, J.M., 2000:
High-efficiency induction of soybean hairy roots and propagation of the soybean cyst nematode

Shen, Y.; Zhao, R.; Berger, S.J.; Anderson, G.A.; Rodriguez, N.; Smith, R.D., 2002:
High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics

Goomer, R.S.; Deftos, L.J.; Terkeltaub, R.; Maris, T.; Lee, M.C.; Harwood, F.L.; Amiel, D., 2001:
High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects

Zhang, Y.; Zhu, J.; Zhang, L.; Zhang, W., 2000:
High-efficiency on-line concentration technique of capillary electrochromatography

Moerner; Schellenberg; Bjorklund; Kaipa; Lüty, 1985:
High-efficiency photochemical hole burning for an infrared color center

Lautanen, J.; Kettunen, V.; Lakkonen, P.; Turunen, J., 2001:
High-efficiency production of propagation-invariant spot arrays

Chen, X.; Liao, J-Long.; Liang, Y.; Ahmed, M.O.; Tseng, H-En.; Chen, S-An., 2003:
High-efficiency red-light emission from polyfluorenes grafted with cyclometalated iridium complexes and charge transport moiety

Li, Z.X.; Schade, U.M.; Fehse, B.; Stockschläder, M.; Uhde, A.; Koch, S.; Goller, B.; Rüger, R.; Fehse, N.; Zander, A.R., 1999:
High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes

Ginzburg; Kaminsky; Kaminsky; Peskov; Sedykh; Sergeev; Sergeev, 2000:
High-efficiency single-mode free-electron maser oscillator based on a bragg resonator with step of phase of corrugation

Kwiat; Steinberg; Chiao; Eberhard; Petroff, 1993:
High-efficiency single-photon detectors

Zeng, M.; Cerniglia, G.J.; Eck, S.L.; Stevens, C.W., 1997:
High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation

Jørgensen, F.; Hansen, O.C.; Stougaard, P., 2002:
High-efficiency synthesis of oligosaccharides with a truncated beta-galactosidase from Bifidobacterium bifidum

Leimig, T.; Brenner, M.; Ramsey, J.; Vanin, E.; Blaese, M.; Dilloo, D., 1996:
High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors

Chiorini, J.A.; Wendtner, C.M.; Urcelay, E.; Safer, B.; Hallek, M.; Kotin, R.M., 1995:
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors

Mengiste, T.; Amedeo, P.; Paszkowski, J., 1998:
High-efficiency transformation of Arabidopsis thaliana with a selectable marker gene regulated by the T-DNA 1' promoter

Woods, R.A.; Gietz, R.D., 2001:
High-efficiency transformation of plasmid DNA into yeast

Kwan, 1986:
High-efficiency, magnetized, virtual-cathode microwave generator

Iguchi, 1993:
High-electric-field behavior of the magnetophonon resonance in polar semiconductors

Nebel; Street; Johnson; Kocka, 1992:
High-electric-field transport in a-Si:H. I. Transient photoconductivity

Nebel; Street; Johnson; Tsai, 1992:
High-electric-field transport in a-Si:H. II. Dark conductivity

Patton, J.A.; Sandler, M.P.; Ohana, I.; Weinfeld, Z., 1996:
High-energy (511-keV) imaging with the scintillation camera

White, S.N.; Yu, Z.; Zhao, X.Y., 1994:
High-energy abrasion: an innovative esthetic modality to enhance adhesion

Mattis; McLerran; Yaffe, 1992:
High-energy anomalous scattering: Is it semiclassical?

Yin; Gabriel; Pratt, 1987:
High-energy atomic photoelectric effect and bremsstrahlung

Clark, N.; Birely, B.; Manson, P.N.; Slezak, S.; Kolk, C.V.; Robertson, B.; Crawley, W., 1996:
High-energy ballistic and avulsive facial injuries: classification, patterns, and an algorithm for primary reconstruction

Robertson, B.C.; Manson, P.N., 2000:
High-energy ballistic and avulsive injuries. A management protocol for the next millennium

Newberger; Tajima, 1989:
High-energy beam transport in crystal channels

Fowler; Friedlander; Weiner; Wilk, 1986:
High-energy behavior of multiparticle distributions and their bounds

Levin; Sellin; Johnson; Lindle; Miller; Berrah; Azuma; Berry; Lee, 1993:
High-energy behavior of the double photoionization of helium from 2 to 12 keV

White, S.L.; Harpaz, N.T.; Jolly, G.P.; Gorecki, G.A., 1999:
High-energy bilateral talar neck fractures secondary to motocross injury

Raineri; Setola; Priolo; Rimini; Galvagno, 1991:
High-energy channeling implants of phosphorus along the silicon

Arakawa, R.; Kobayashi, M.; Nishimura, T., 2000:
High-energy collision-induced dissociation of small polycyclic aromatic hydrocarbons

Harvey, D.J.; Bateman, R.H.; Green, M.R., 1997:
High-energy collision-induced fragmentation of complex oligosaccharides ionized by matrix-assisted laser desorption/ionization mass spectrometry

Gerbaux, P.; Sciamanna, V.; Flammang, R.; Nguyen, M.T., 2001:
High-energy collisional activation of the molecular ions of thiophene-2-one with different target gases

Minakata; Smirnov, 1996:
High-energy cosmic neutrinos and the equivalence principle

Lamm; Wiss; Avery; Butler; Gladding; Goodman; O'Halloran; Russell; Wattenberg; Busenitz; Callahan; Olszewski; Binkley; Cumalat; Gaines; Gormley; Peoples; Harding; Atiya; Hartouni; Holmes; Knapp; Lee; Seto; Wisniewski, 1987:
High-energy diffraction dissociation of KL0 into exclusive final states

Dahm, J.B.; Kuon, E., 2000:
High-energy eccentric excimer laser angioplasty for debulking diffuse iIn-stent restenosis leads to better acute- and 6-month follow-up results

Kundrát; Lokajícek; Krupa, 1992:
High-energy elastic hadron scattering in Coulomb and hadronic regions

Menard, C.M.; Bews, J.; Skoracki, R.I.; Chowdhury, A.D., 2000:
High-energy electron and photon therapy to the parotid bed: radiation dose perturbations with a titanium mandibular implant

Giulietti, D.; Galimberti, M.; Giulietti, A.; Gizzi, L.A.; Borghesi, M.; Balcou, P.; Rousse, A.; Rousseau, J.P., 2001:
High-energy electron beam production by femtosecond laser interactions with exploding-foil plasmas

Zhang; Ross; Fink, 1991:
High-energy electron scattering study of molecular hydrogen

Zhengming; Brahme, 1992:
High-energy electron transport

Kielwein; Saiki; Roth; Fink; Paasch; Egdell, 1995:
High-energy electron-energy-loss study of sodium-tungsten bronzes

Casalbuoni; D.C.rtis S.D.minici; Feruglio; Gatto, 1989:
High-energy equivalence theorem in spontaneously broken supergravity

Rompe, J.D.; Rosendahl, T.; Schöllner, C.; Theis, C., 2001:
High-energy extracorporeal shock wave treatment of nonunions

Nesbet; Geltman, 1986:
High-energy forward elastic scattering of electrons: Partial-wave approximations

Weigel, D.P.; Marsh, J.Lawrence., 2002:
High-energy fractures of the tibial plateau. Knee function after longer follow-up

Gossett; Behr; Luke; McLain; Rosenzweig; Snover; Hering, 1990:
High-energy gamma emission in heavy-ion collisions at 9-14 MeV/nucleon

Kerr, G., 1996:
High-energy gamma rays at Hiroshima and Nagasaki

Murakami; Benenson; Chen; Clayton; Kashy; Stevenson; Tam; Hanold; Mohar, 1989:
High-energy gamma rays from reactions induced by E/A=15 MeV heavy-ion beams

Stevenson; Beard; Benenson; Clayton; Kashy; Lampis; Morrissey; Samuel; Smith; Tam; Winfield, 1986:
High-energy gamma-ray emission in heavy-ion collisions

Tam; Stevenson; Benenson; Clayton; Chen; Kashy; Lampis; Morrissey; Samuel; Murakami; Winfield, 1988:
High-energy gamma-ray production in light-ion induced reactions

Clayton; Stevenson; Benenson; Chen; Kashy; Lampis; Samuel; Tam; Mohar; Morrissey; Murakami; Sherrill; Winfield, 1989:
High-energy gamma-ray production in the heavy-ion reaction 136Xe + Sn at E/A=89 and 124 MeV

Vásconez, H.C.; Shockley, M.E.; Luce, E.A., 1996:
High-energy gunshot wounds to the face

Ornik; Pottag; Weiner, 1989:
High-energy heavy-ion reactions and relativistic hydrodynamics in three dimensions

Kanca, J., 2001:
High-energy illumination of the truth, or the serial endorser?

Courant; Pellegrini; Zakowicz, 1985:
High-energy inverse free-electron-laser accelerator

Smith; Hennessy; Kim; Whang; Worthington; Mingde, 1987:
High-energy ion-scattering studies of anisotropic surface-atom vibrations on W(110)

Matiushichev, V.B.; Soldatov, A.I., 1994:
High-energy laser irradiation in the combined treatment of duodenal ulcer

Lapchenko, A.S., 2002:
High-energy laser radiation in otorhinolaryngology: past and future

Teodorovich, O.V.; Mulabaev, S.K., 1997:
High-energy laser technologies in the treatment of patients with benign prostatic hyperplasia

Matiushichev, V.B.; Soldatov, A.I.; Linkevich, E.L., 1997:
High-energy laser therapy of stomach ulcers

Sandvik, A.W.; Singh, R.R., 2001:
High-energy magnon dispersion and multimagnon continuum in the two-dimensional Heisenberg antiferromagnet

Cornwall; Tiktopoulos, 1992:
High-energy multileg electroweak processes and unitarity

Stecker; Done; Salamon; Sommers, 1991:
High-energy neutrinos from active galactic nuclei

Atoyan, A.; Dermer, C.D., 2001:
High-energy neutrinos from photomeson processes in blazars

d'Errico, F.; Agosteo, S.; Sannikov, A.V.; Silari, M., 2002:
High-energy neutron dosimetry with superheated drop detectors

Hwa; Wang, 1990:
High-energy nuclear collisions in the geometrical branching model

Frankfurt; Miller; Strikman, 1992:
High-energy nuclear quasielastic reactions: Decisive tests of nuclear-binding/pion models of the European Muon Collaboration effect

Durand; Pi, 1988:
High-energy nucleon-nucleus scattering and cosmic-ray cross sections

Loong; Vashishta; Kalia; Degani; Price; Jorgensen; Hinks; Dabrowski; Mitchell; Richards; Zheng, 1989:
High-energy oxygen phonon modes and superconductivity in Ba1-xKxBiO3: An inelastic-neutron-scattering experiment and molecular-dynamics simulation

Murani; Eccleston, 1996:
High-energy paramagnetic spectral response of CeNi2

Routt, M.L.Chip.; Nork, S.E.; Mills, W.J., 2002:
High-energy pelvic ring disruptions

Samaja, M.; Allibardi, S.; D.J.nge, R.; Chierchia, S.L., 1999:
High-energy phosphates metabolism and recovery in reperfused ischaemic hearts

Thevuthasan; Ynzunza; Tober; Fadley; Kaduwela; Van Hove MA, 1993:
High-energy photoelectron holography for an adsorbate test system: c(2 x 2)S on Ni(001)

Honjo; Durand; Gandhi; Pi; Sarcevic, 1993:
High-energy photon-nucleon and photon-nucleus cross sections

Chakrabarty; Alam; Srivastava; Sinha; Raha, 1992:
High-energy photons from expanding quark-gluon plasma and hot hadronic matter

Kapusta; Lichard; Seibert, 1991:
High-energy photons from quark-gluon plasma versus hot hadronic gas

Nakayama, 1989:
High-energy photons in neutron-proton and proton-nucleus collisions

Kallianpur, 1986:
High-energy photoproduction of W bosons

Collins; Ladinsky, 1991:
High-energy photoproduction of jets

Busenitz; Olszewski; Callahan; Gladding; Wattenberg; Binkley; Butler; Cumalat; Gaines; Gormley; Harding; Loveless; Peoples, 1989:
High-energy photoproduction of pi + pi - pi 0, K+K-, and pp-bar states

Seife, C., 2002:
High-energy physics. Atom smasher probes realm of nuclear 'gas'

Irion, R., 2001:
High-energy physics. B-meson factories make a "number from hell"

Seife, C., 2002:
High-energy physics. CERN council chooses ITER's head as chief

Weiss, G., 2002:
High-energy physics. CERN panel calls for cuts and shake-ups

Weiss, G., 2002:
High-energy physics. Cost overruns will hit research at CERN

Seife, C., 2001:
High-energy physics. Muon experiment challenges reigning model of particles